Patients at hospitals and other care centers regularly require controlled drug intake as a part of the patient's prescribed therapy. One form of controlled drug intake is accomplished by infusing fluidic drugs with a medical infusion pump.
Medical infusion pumps, in general, provide regulated drug delivery to a patient. These pumps are used to deliver a selected drug or other therapeutic agent to a patient at a predetermined rate that is programmed into the pump. However, programming and managing such pumps can be difficult and cumbersome. Programming typically includes preloading a pump program into a pump and then entering pump parameters or data into the pump through a keypad that is directly in the pump. Each time the pump is programmed, the data must be reentered by hand.
Managing the status and locations of pumps also can be difficult. A single pump can be us programmed for delivering different fluids in different therapies and in different locations within a hospital. Similarly, the status of a pump and alarms can be difficult to monitor because the pumps are often in locations other than where the caregiver is located and have small displays on which information can be difficult to see.
According to a first aspect, an apparatus for indicating a change in operation of a medical infusion pump is disclosed. The apparatus includes a memory configured to store an original pump parameter and a non-original pump parameter. The apparatus further includes a monitor. The apparatus also includes a programmable circuit in electrical communication with the memory and the monitor. The programmable circuit is programmed to display on the monitor the original pump parameter and the non-original pump parameter, the non-original pump parameter being displayed juxtaposed to the original pump parameter.
According to a second aspect, an apparatus for indicating a change in operation of a medical infusion pump is disclosed. The apparatus includes a memory configured to store an original pump parameter and a current pump parameter. The apparatus further includes a programmable circuit in electrical communication with the memory, the programmable circuit programmed to display the original pump parameter and the current pump parameter.
According to a third aspect, a method of indicating a change in operation of a medical infusion pump is disclosed. The method includes storing an original pump parameter. The method also includes storing a current pump parameter. The method further includes displaying the original pump parameter and the current pump parameter.
Various embodiments will be described in detail with reference to the drawings, wherein like reference numerals represent like parts and assemblies throughout the several views. Reference to various embodiments does not limit the scope of the claims attached hereto. Additionally, any examples set forth in this specification are not intended to be limiting and merely set forth some of the many possible embodiments for the appended claims.
The following discussion is intended to provide a brief, general description of a suitable computing environment in which the invention may be implemented. Although not required, the invention will be described in the general context of computer-executable instructions being executed by a computer, for example, a hand held computer, a personal computing system, or a medical infusion pump. The structure, creation, and use of a message store hierarchical folder structure are described after the discussion of an exemplary operating environment.
Additionally, the logical operations of the various embodiments of the invention described herein are implemented as: (1) a sequence of computer implemented operations running on a computing system; and/or (2) interconnected machine modules within the computing system. Modules represent functions executed by program code such as commonly available programming languages or as the code found in a dynamic-link library (DLL). The implementation used is a matter of choice dependent on the performance requirements of the pump and the computing systems with which it interfaces. Accordingly, the logical operations making up the embodiments of the invention described herein can be referred to alternatively as operations, modules, and the like.
The computing system 104 is configured to execute computer-readable instructions, such as computer software. The computing system 104 can be located in a variety of locations such as the point of care (POC) where a patient is being treated, in a healthcare facility at a location remote from the POC, or even at an off-site location remote from the healthcare facility itself. In further embodiments, the medical infusion pump 102 acts as the computing system 104.
In the exemplary embodiment, the computing system 104 is programmed to generate and store pump protocols for execution in the context of a pump application program. Each pump protocol includes a series of pump parameters. Pump parameters refer to settings that define an operational aspect of a medical infusion pump. The pump parameters dictate the control of the pump.
Pump protocols are collections of these pump parameters defining the variable operational characteristics of a medical infusion pump during application of a specific therapy, qualifier, and drug. The pump protocol includes a listing of operational parameters to be included in the pump, and correlates to an index for referring to a specific protocol containing a specific set of pump parameters. The index can be associated with a therapy, qualifier, and drug, and is either contained within the protocol or associated with a specific protocol. The pump protocol includes patient specific pump parameters and non-patient specific pump parameters. Patient specific pump parameters refer to those parameters which are set on a patient-by-patient basis, and for example include the basal delivery rate or bolus amount. Non-patient specific pump parameters refer to those parameters which are set for the pump to perform specific tasks, and do not account for the specific patient to which they are applied. These parameters are generally related to the pump, the infusion pump network, or the medical care to be provided by the pump and/or pump network. Non-patient specific pump parameters can include, for example, a range of permissible values for basal delivery, a range of values and patterns for basal delivery, a range of permissible values for boluses, a range of values and patterns for extended boluses, a starting value within a particular range of values, alarm values, protocols for data communication, and various flag settings.
A pump application program is a program having instructions (e.g., executable code, rules, and/or data) that control operation of the pump for a specific therapy or type of delivery (e.g., continuous delivery, intermittent delivery, pain control, chemotherapy, total parenteral nutrition, etc.). For example, a pump application program might contain instructions that define operation of a pump to accomplish various of the pump parameters. Pump application programs include, for example, pump protocols including both patient specific and non-patient specific pump parameters, and instructions for allocating memory, user interfaces, or algorithms for monitoring various sensors and driving a motor for the pump mechanism.
The communications link 106 connects the pump 102 and computing system 104. In various embodiments, the communications link 106 can include serial or parallel connections, wired or wireless connections, and a direct or networked connection to a computer. Additionally, the pump 102 and the computing system 104 can communicate using any protocol appropriate for data communication. Examples of network connections to a computer include Intranet, Internet, and LAN (e.g., Ethernet). Examples of wired connections to a computer include USB, RS-232, Firewire, and power-line modem connection. Examples of wireless connections include bluetooth, 802.11a/b/g, infrared (IR), and radio frequency (RF).
In the exemplary embodiment, the individual computing systems 104n execute software for generating and managing pump application programs and sets of pump operating parameters. The pump application programs and sets of pump operating parameters are stored on the server 206 so they can be accessed by other individual computing systems 104n. The individual computing systems 104n are also programmed to retrieve previously created pump application programs and sets of pump operating parameters that are stored on the server 206 for viewing, editing, and downloading to medical infusion pumps 102n.
In alternative embodiments, the medical infusion pumps 102n can directly access the server to retrieve pump application programs and sets of pump operating parameters. For example, the medical infusion pumps 102n can be loaded with client software such as a web browser and communicate directly with the network 200, either through a wired or wireless connection as described herein.
In other alternative embodiments, one or more of the computing systems is not configured to communicate directly with a medical infusion pump 102n, but rather provides administrative access to the server 206 for generating, viewing, and editing pump application programs and sets of pump operating parameters. Additionally, servers, workstations, and other computing systems unaffiliated with the medical infusion pumps 102n can be included in the network 200.
In yet other alternative embodiments, the software is executed in the server 206. For example, the server functions as an application service provider that communicates user interface and other data entries in mark-up language such as HTML or some other language or protocol that allows a user to execute software from a remote location. In these embodiments, the server 206 can function as an application service provider in which the server provides access to the software for generating and storing pump application programs and pump protocols that a user can create and download to a medical infusion pump. For example, the server 206 could be located at a pump manufacture, pharmaceutical manufacture, pharmacist, or some other third party separate from the user. The server 206 in such an embodiment can be accessed either from an individual computing system 104 or by a medical infusion pump 102 that has networking capabilities and client software.
Example embodiments of a server 206 and a medical infusion pump 102 having a web browser are disclosed in U.S. patent application Ser. No. 11/066,425, which was filed on Feb. 22, 2005 and is entitled Server for Medical Device, the entire disclosure of which is hereby incorporated by reference.
The computing system 300 including at least one processing system 302. A variety of processing units are available from a variety of manufacturers, for example, Intel or Advanced Micro Devices. The computing system 300 also includes a system memory 304, and a system bus 306 that couples various system components including the system memory 304 to the processing unit 302. The system bus 306 may be any of a number of types of bus structures including a memory bus, or memory controller; a peripheral bus; and a local bus using any of a variety of bus architectures.
The system memory 304 can include read only memory (ROM) 308 and random access memory (RAM) 310. A basic input/output system 312 (BIOS), containing the basic routines that help transfer information between elements within the computing system 300, such as during start up, is typically stored in the ROM 308.
The computing system 300 can also include a secondary storage device 313, such as a hard disk drive, for reading from and writing to a hard disk (not shown), and/or a compact flash card 314.
The hard disk drive 313 and compact flash card 314 are connected to the system bus 306 by a hard disk drive interface 320 and a compact flash card interface 322, respectively. The drives and cards and their associated computer readable media provide nonvolatile storage of computer readable instructions, data structures, program modules and other data for the computing system 300.
Although the exemplary environment described herein employs a hard disk drive 313 and a compact flash card 314, other types of computer-readable media, capable of storing data, can be used in the exemplary system. Examples of these other types of computer-readable mediums include magnetic cassettes, flash memory cards, digital video disks, Bernoulli cartridges, CD ROMS, DVD ROMS, random access memories (RAMs), or read only memories (ROMs).
A number of program modules may be stored on the hard disk 313, compact flash card 314, ROM 308, or RAM 310, including an operating system 326, one or more application programs 328, other program modules 330, and program data 332. A user may enter commands and information into the computing system 300 through an input device 334. Examples of input devices might include a keyboard, mouse, microphone, joystick, game pad, satellite dish, scanner, digital camera, touch screen, and a telephone. These and other input devices are often connected to the processing unit 302 through an interface 340 that is coupled to the system bus 306. These input devices also might be connected by any number of interfaces, such as a parallel port, serial port, game port, or a universal serial bus (USB). Wireless communication between input devices and interfaces 340 is possible as well, and can include infrared, bluetooth, 802.11a/b/g, cellular, or other radio frequency communication systems. A display device 342, such as a monitor or touch screen LCD panel, is also connected to the system bus 306 via an interface, such as a video adapter 344. The display device 342 might be internal or external. In addition to the display device 342, computing systems, in general, typically include other peripheral devices (not shown), such as speakers, printers, and palm devices.
When used in a LAN networking environment, the computing system 300 is connected to the local network through a network interface or adapter 352. When used in a WAN networking environment, such as the Internet, the computing system 300 typically includes a modem 354 or other communications type, such as a direct connection, for establishing communications over the wide area network. The modem 354, which can be internal or external, is connected to the system bus 306 via the interface 340. In a networked environment, program modules depicted relative to the computing system 300, or portions thereof, may be stored in a remote memory storage device. It will be appreciated that the network connections shown are exemplary and other methods of establishing a communications link between the computing systems may be used.
The computing system 300 might also include a recorder 360 connected to the memory 304. The recorder 360 includes a microphone for receiving sound input and is in communication with the memory 304 for buffering and storing the sound input. The recorder 360 also can include a record button 361 for activating the microphone and communicating the sound input to the memory 304.
A computing device, such as computing system 300, typically includes at least some form of computer-readable media. Computer readable media can be any available media that can be accessed by the computing system 300. By way of example, and not limitation, computer-readable media might comprise computer storage media and communication media.
Computer storage media includes volatile and nonvolatile, removable and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data. Computer storage media includes, but is not limited to, RAM, ROM, EEPROM, flash memory or other memory technology, CD-ROM, digital versatile disks (DVD) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium that can be used to store the desired information and that can be accessed by the computing system 300.
Communication media typically embodies computer-readable instructions, data structures, program modules or other data in a modulated data signal such as a carrier wave or other transport mechanism and includes any information delivery media. The term “modulated data signal” refers to a signal that has one or more of its characteristics set or changed in such a manner as to encode information in the signal. By way of example, and not limitation, communication media includes wired media such as a wired network or direct-wired connection, and wireless media such as acoustic, RF, infrared, and other wireless media. Combinations of any of the above should also be included within the scope of computer-readable media. Computer-readable media may also be referred to as computer program product.
The pump motor 404 drives a drive mechanism 412. The drive mechanism 412 delivers the therapeutic fluid to a patient. The drive mechanism can be connected to a plunger system, a peristaltic drive mechanism, or another type of fluid delivery system.
The screen 406 can have many different configurations such as an LCD screen. The screen 406 displays a user interface that presents various items of information useful to a patient or caregiver. The audible alarm 408 is a beeper, and an alarm provides actual alarms, warnings, and reminders. Similar to other portable electronic devices such as a cellular telephone, the vibratory alarm 410 provides an alarm to either supplement the audio alarms or replace the audio alarm when an audible beep would be disruptive or not heard. A user can selectively enable or disable the audible 408 and vibratory 410 alarms. In one possible embodiment, however, both the audible 408 and vibratory 410 alarms cannot be disabled at the same time.
The microprocessor 402 is in electrical communication with both a random access memory (RAM) 416 and a read only memory (ROM) 418, which are onboard the pump 400 but external to the microprocessor 402 itself. In one possible embodiment, the microprocessor 402 includes internal memory as well. The RAM 416 is a static RAM stores that data that can change over time such as pump settings and a historical log of events experienced by the medical infusion pump 400. The ROM 418 stores code for the operating system and the application programs. The ROM 418 can be any type of programmable ROM such as an EPROM. In one possible embodiment, the RAM 416 has 500 kilobytes of memory capacity and the ROM 418 has 2 megabytes of memory capacity.
An infrared (IR) port 420 is in electrical communication with the microprocessor. As explained in more detail below, the IR port 420 provides data communication with an external device such as a computer for programming an application program, programming pump settings, and downloading historical data logs. The medical infusion pump 400 can include other types of communication ports in place of or in addition to the IR port 420. Examples of other possible communication ports include a radio frequency (RF) port or a port that provides a hard-wired data communication link such as an RS-232 port, a USB port, or the like.
A real-time clock 422 provides a clock signal to the microprocessor 402. An advantage of having a real-time clock 422 is that it provides the program with the actual time in real-time so that the programs executed by the medical infusion pump can track and control the actual time of day that drug delivery and other events occur. Various durations described here are used for alerts, alarms, reminders, and other functions. In one possible embodiment, the timers are formed by the real-time clock 422 and software executed by the microprocessor 402.
A keypad 424 also provides input to the microprocessor 402. Although other possible types of keypads are possible, one type of keypad has four buttons and is a membrane-type of keypad, which provides resistance to water and other environmental conditions. The keypad 424 contains soft keys for which the function of the keys can change as a user executes different menu selections and commands.
An audio bolus button 425 optionally provides input to the microprocessor 402. The audio bolus button 425 can program the pump 400 to audibly administer a bolus of drugs or other therapeutic fluids without requiring visual confirmation using the pump. In an example embodiment, the audio bolus button 425 can be pressed a series of times to trigger bolus delivery of a selected volume, based on a preprogrammed trigger granularity. A single button press can represent a bolus of 5 grams, as selected by a user, and subsequent presses of the audio bolus button can represent multiples thereof.
Other inputs into the microprocessor 402 can include an occlusion sensor 426, which is sensitive to occlusions in the therapeutic fluid delivery line; a cartridge sensor 428, which is sensitive to the presence of a therapeutic fluid cartridge; and a motion detector 430, which detects motion of a gear (not shown) in the drive mechanism 412. In an exemplary embodiment, the cartridge sensor 428 includes one or more sensors configured to detect insertion of a therapeutic fluid cartridge. The pump 400 can detect the type of cartridge present via a mechanical interface, and can include in the pump software instructions regarding operation in conjunction with the cartridge. Examples of cassette sensing features are described, for example, in U.S. Pat. No. 5,531,697, filed on Apr. 15, 1994, issued on Jul. 2, 1996, and entitled Systems and Methods for Cassette Identification for Drug Pumps.
The administrator computer 502 and computing systems 104 are systems such as those described above in conjunction with
In the present disclosure, libraries refer to collections of pump protocols generated using the administrative software described herein. Libraries can be stored in files, databases, or other data structures. Libraries contain pump protocols as well as indices pointing to the protocols, and are loaded in user software to select a specific pump protocol for operation of a medical infusion pump.
The computing systems 104 include user software for accessing one or more libraries 508 of protocols 510 and programming a medical infusion pump 102 with a protocol 510 or a library 508. In one possible embodiment, the computing systems 104 are optional in that the user software resides directly on the medical infusion pumps 102. An exemplary embodiment of the user software is described below in
The medical infusion pumps 102 connect either to a computing system 104 or directly to the server 206, and are described above in conjunction with
The database 504 contains pump protocol data 506 and log files 516. The pump protocol data 506 forms a plurality of libraries 508 which in turn each include a number of protocols 510. Each protocol 510 is stored as a data record, and includes a set of parameters, including patient specific pump parameters 512a and non-patient specific pump parameters 512b, as described above. Each library 508 can contain one or more pump protocols 510.
The log files 516 include log data regarding access and usage of the libraries 508, and can include information related to the administrator computer 502, the medical infusion pumps 102, or the computing systems 104 authorized to connect to the server 206. In one possible embodiment, the log files include access records, which record instances in which medical infusion pumps access a library 508 on the server 206.
The total number of pump parameters 512a-512b remains constant for each particular model of pump, but can vary between types of pumps. Additionally, the pump parameters 512a-512b can be configured in a number of formats within each protocol 510 for the same type of pump. For example, the number of patient specific pump parameters 512a can vary between protocols due to the specific type of drug and therapy applied. For example, a protocol defining a continuous drug delivery may only require a single patient specific protocol, namely, the drug delivery rate. In another example, a protocol defining intermittent drug delivery may require additional patient specific pump parameters, such as the time between drug delivery phases, a bolus amount, patient bolus amounts, and other parameters. The number of non-patient specific pump parameters 512b represents the difference between the total number of parameters programmable into a pump and the number of patient specific pump parameters 512a as dictated by the therapy and drug applied.
The index 514 can be any generic index referencing a specific location within the library. Each index is unique within the library, although another library may contain the same index and relate that index to a different set of pump parameters contained within that library. In the exemplary embodiment shown, the index 514 includes therapy, qualifier, and drug regions. By selecting a combination of a therapy, a qualifier, and a drug, a user of the system can select one of the protocols 510 from the library 508. Therapies, as referred to herein, are the methods of patient treatment for diseases or generalized rehabilitation. For example, a therapy can be an epidural treatment or patient-controlled analgesia. Qualifiers include factors affecting the administration of a therapy, such as weight, age, or sensitivity of a patient to a specific therapy. Drugs refer to any therapeutic fluids deliverable by a medical infusion pump.
Each of the protocol entries on the server can be assigned an identification code in order to ensure that the medical infusion pumps access a correct library and/or protocol, and that the protocols on the medical infusion pumps and computing systems associated with the server 206 of
In another possible embodiment, the pump protocol 510 is selected using the infusion pump 102 or the computing system 104. The pump protocol 510 is then incorporated into a pump program to provide a set of instructions dictating the operation of a medical infusion pump 102 according to the protocol 510. The complete pump program is then downloaded into the pump 102. In yet another possible embodiment, the pump program is downloaded to the pump 102 at a different time from the pump protocol 510. In still a further embodiment, multiple pump programs reside within the pump 102, and the pump protocol 510 contains a parameter which dictates which pump program is to be used. In a further embodiment, the pump program within the pump is altered based on one or more of the pump parameters included in the pump protocol 510.
The administrative software 700 allows a user, for example a doctor, nurse, pharmacist, or other caregiver, to create, define, and edit pump application programs and protocols for execution in and control of medical infusion pumps 102. For example, the administrative software 700 can generate protocols and programs that can be loaded using the user software described in
The administrative software 700 provides protocol-based programming of medical infusion pumps in which the user creates a pump application program by designating a particular therapy and other criteria such as a location and qualifiers (e.g., patient age, weight, skin surface area). Once criteria are selected, the administrative software 700 applies rules and other logic that assembles sets of pump parameters into a pump protocol. For example, the administrative software 700 might be used to select one delivery pattern and enable bolus delivery if the selected therapy is for delivering pain medication and another delivery pattern and not enable bolus delivery if the selected therapy is for parenteral nutrition. In another example, the administrative software 700 might be used to select one range of permissible delivery rates if one of the criteria indicates the patient is an adolescent and different range of permissible delivery rates if the patient is an adult. Other embodiments permit programming a medical infusion pump 102 without using therapy-based programming. Additional embodiments of protocol- or therapy-based programming is discussed in more detail in U.S. patent application Ser. No. 11/003,147, filed on Dec. 3, 2004 and entitled Programming Medical Pumps with Electronic Standing Order Template, the entire disclosure of which is hereby incorporated by reference.
Operation of the software 700 begins at a start module 702. The start module 702 corresponds to initial execution of the administrative software by clicking on an icon on the computer or by some other mechanism for executing software. Upon startup, the software 700 connects to a library loaded in the database 504 of
Following the start module, operational flow optionally proceeds to a load library module 704, which allows a user to access a listing of library files available to the administrative software 700. The library files contain one or more libraries, which in turn contain a collection of pump protocols as described above. The collection of library files can be stored in the server 206 or in one or more individual computing systems 102. The load library module 704 allows the user to select a library file containing one or more libraries for viewing, editing, and downloading to a medical infusion pump 102. If a user does not want to download or otherwise access an existing library, it can selectively bypass the load library module 704. An example of when a user bypasses the load library module 704 is if the user plans to only create a new library or edit one or more protocols within the currently loaded library. In an alternative embodiment, the software always executes the load library module 704 and the user then selectively chooses whether to load any previously created libraries via a stored library file.
Following the start module 702 and optional load library module 704, operational flow proceeds to a login module 706. The login module 706 regulates user rights in the software 700. User rights define access levels to the currently connected library in user software, and are configurable for users such as doctors, nurses, or other caregivers. Based on the user rights assigned to a caregiver, that user will have a set access level allowing the user to view, add, or edit pump libraries within the user software, described in detail below. Access levels can be set according to a variety of criteria. Examples include the type of caregiver (e.g., physician, nurse, pharmacist), location (e.g., hospital, clinic, pharmacy, manufacturer), or a particular department within a location.
In possible embodiments, different access levels also provide different rights with respect to a particular pump protocol or pump operational parameters. For example, one access level might give a user a right to edit, create, and download pump protocols and/or pump application programs. One access level might permit a user the right to edit, create, and download only specified pump parameters, such as the patient specific pump parameters described in conjunction with
Once the user is logged in and the library is optionally loaded, the user selectively executes three different modules, a library module 708, a therapy module 710, and a protocol module 712.
The library module 708 assigns a label that identifies an entity and user attributes for the selected entity. Entity attributes can be properties specific to the library, such as a name of a doctor, a name of a healthcare regimen, or a location of the medical infusion pump or pump network, for example the hospital or department at which the pump is located. User attributes define the users allowed to access and modify pump parameters for protocols associated with a particular library by using the medical infusion pump, and can also define users allowed to modify pump protocols using user software, as described below. The library module 708 contains a library definition module 714 and a user rights module 716, which are configured to perform these tasks, respectively.
The therapy module 710 adds and modifies therapies, qualifiers associated with the therapies, and drugs. The therapy module includes a therapy definition module 718, a qualifier definition module 720, and a drug definition module 722. The therapy definition module 718 controls addition and editing of therapies, which are the methods of patient treatment for diseases or generalized rehabilitation as previously described. The qualifier module 720 defines qualifiers and associates the qualifiers with one or more therapies. The drug definition module 722 defines one or more drugs that can be used in the medical infusion pump.
The protocol module 712 adds, edits, and defines protocols by associating therapies, qualifiers, and drugs with pump parameters to form libraries of pump protocols for a medical infusion pump. The protocol module 712 allows a user to select a therapy defined in the therapy definition module 718. The protocol module further allows the user to associate a qualifier defined in the qualifier definition module 720 with the selected therapy. For example, one or both of “adults” and “children 5-10 years” qualifiers can be associated with an epidural therapy. The protocol module 712 also associates one or more drugs with each therapy and qualifier combination, indicating that use of the drug is appropriate for that therapy and qualifier. The protocol module 712 guides the user in defining a protocol by assigning default pump parameters to be associated with the selected therapy, qualifier, and drug.
The protocol module 712 allows a user to associate more than one qualifier to each therapy, and also allows a user to associate more than one drug to each therapy and qualifier combination. For example, a protocol used in an epidural therapy for an adult can include a higher basal delivery rate parameter than a protocol used with a child for the same therapy. Likewise, usage of one drug can require a higher or lower dosage than another drug for the same therapy and qualifier because of concentration, reaction, or other factors.
Operational flow proceeds from the modules 708, 710, 712 to an optional export library module 724. The export library module 724 saves the defined or edited pump application programs and parameters in a file or other data structure that can be loaded by the administrative software 700 at another time or location, or can be loaded by user software such as described below in
Operation of the software 700 terminates at an end module 726. The end module 726 corresponds to termination of the administrative software 700 by clicking on a close window button on the computer or by some other mechanism for terminating execution of software.
In one embodiment of the administrative software 700, a user of the software 700 defines each protocol included in a library. In defining each protocol, the user assigns the index to the protocol, such as the therapy, qualifier, and drug defined in the modules 708, 710, 712 above. In a second possible embodiment, the administrative software includes a number of default settings or pump parameter modifications used when specific therapies, qualifiers, or drugs are selected. The user selects a therapy, qualifier, and drug to associate with a pump protocol. The administrative software 700 can include instructions dictating that selection of one or more of the therapies, qualifiers, and drugs sets or modifies one or more of the patient specific pump parameters or non-patient specific pump parameters. In one example of this second embodiment, a user setting a drug having a maximum safe consumption rate will trigger the administrative software 700 to preset an acceptable range of programmable delivery rates and a default delivery rate in the protocol, as well as alarms or other non-patient specific pump parameters. In another possible example of this second embodiment, a user setting a qualifier indicating a low age, such as “Children 5-10 years old”, will set or adjust the protocol to result in a low delivery rate and demand dose being incorporated into the protocol, and will set one or more parameters related to alarms for use in a medical infusion pump.
Referring now to
The file selection field 802 displays one or more library files that are available to be selected. The file selection field 802 allows a user to select one or more of the protocol library files, in conjunction with selection control buttons 806a, 806b. The password field 804 controls access to the selected library file by requiring a user to input a correct password associated with the selected file, or library within the file.
A location field 808 presents the directory path of the selected library file and a browse button 810 provides browsing capabilities to allow a user to find a library file other than those displayed in the library selection field 802.
In use, the library import screen 800 initially presents a listing of library files in the file selection field 802 available to the administrative software. The user selects one of the displayed library files, or presses the browse button 810 to search for additional library files. The user selects a library file by clicking on the displayed library file, or by other selection method. The directory path of the selected library file appears in the location field 808, and the user then enters a password in the password field 804 corresponding to the selected library file. The user confirms the choice using the selection control buttons 806a, 806b. The administrative software confirms that the user-entered password is correct, and accesses the library file.
Referring now to
Global control features included in the user interface 900 relate to library and pump access settings. A library field 902 provides a listing of libraries currently loaded by the software. The library field 902 contains the libraries which have been loaded using the load library module 704 of
The user interface 900 can display information related to the status of the network of medical infusion pumps. A database identification field 906 identifies the database 504 currently connected to the administrator computer 502, as shown in
The user interface 900 also includes a location tab 920, a therapy tab 940, and a protocol tab 960. Referring back to
Referring now to
A region of the location tab 920 supersedes the therapy tab 940 and protocol tab 960. Within the region exposed by the location tab 920, a library selected in the library field 902 populates a library description field 1002 and a user accounts field 1004. The library description field 1002 describes the library that is currently loaded, and includes attributes of the location in which the library is used, or other information about the library. The location attributes can include the name of the hospital or the department in the hospital associated with the library. The additional information can include information related to the users of the library, the contents of the library, or other information. The library description field 1002 corresponds to the location attributes module 714 of
In a possible embodiment, a log report field 1008 can optionally direct the server 206 to generate a record for various events occurring in the database 504. For example, a log report can be created each time a protocol is sent to a medical infusion pump 102. Alternately, a log report is created each time a library is sent to a medical infusion pump 102. In further embodiments, a log report is created each time a library is edited or accessed. In still further embodiments, globally unique identifiers are entered into the log report related to instances where computing systems 104 and/or infusion pumps 102 access a library in the database 504. In the embodiment shown, the log report field 1008 is a selectable check box, but can be implemented as any other type of selectable field.
A password field 1010 sets a password for the currently selected library file. The password protects access to the library from the perspective of user software residing on either a computing system 104 or an infusion pump 102 such that only users with knowledge of the password associated with the library file can load the library using the load library module 704 of
Referring now to
The therapy definition field 1102 corresponds to the therapy definition module 718 of
The qualifier definition field 1104 corresponds to the qualifier definition module 720 of
The drug definition field 1106 corresponds to the drug definition module 722 of
Referring now to
The control buttons 1204a-1204e operate to add, edit, view, and/or delete the protocol for the combinations of therapies, qualifiers, and drugs. The control buttons 1204a-1204d allow a user to set pump parameters so as to define the protocol. Control button 1204e generates a prescription form screen representing the protocol for the selected therapy, qualifier, and drug.
The bar code screen 1300 includes a print preview field 1302, a printer drop down menu 1304, a label information menu 1306, a copies drop down menu 1308, and control buttons 1310a-1310c. The print preview field 1302 displays a bar code associated with the selected drug. The printer drop down menu 1304 lists available printers configured to print the bar code. The label information drop down menu 1306 defines the label configuration to which the bar code is directed. The label configuration includes, for example, the size and layout of the label paper. The copies drop down menu 1308 dictates the number of copies of the bar code that are printed. Control buttons 1310a-1310c provide printing, cancellation, and help procedures to a user.
In use, the bar code corresponds to a drug identification code associated with the drug. In a possible embodiment, a pharmacist can print the barcode associated with the drug using the administrative software 700 via the bar code screen 1300 and affix the printed bar code label to the drug container. The labels indicate the drug and dosage being delivered by the pump. This provides an easily accessible and visually prominent indication of the drug being delivered by a medical infusion pump.
A caregiver connecting a drug to a medical infusion pump 102 will scan the bar code on the drug container, which will correspond to the drug identification code associated with the drug in the administrative software 700. This ensures that the caregiver affixes the drug to the pump which corresponds to the protocol selected using administrative software 700.
A doctor using the prescription form dictates the protocol used in the pump by using a prescription form analogous to the prescription form screen. The prescription form 1400 generated by the administrative software will correspond to the prescription form completed by the doctor. In the embodiment shown, the prescription form screen 1400 that is generated includes information specific to the drug and therapy administered, which may be notes related to administration of the drug and therapy as dictated by the doctor. For example, the prescription form will include drug information, such as the name, type, concentration, and notes regarding the drug, and will also include information related to patient specific pump parameters associated with a selected therapy, qualifier, and drug selected from a library.
Referring now to
Analogously, upon selection of a drug from the drug drop down menu 1510, drug notes (not shown) appear in the drug notes field 1512.
Referring now to
The parameter user interface 1800 includes a status region 1802, a protocol activation field 1804, and control buttons 1806a-1806c. The status region 1802 displays the therapy, qualifier, and drug associated with the assignable pump parameters. The protocol activation field 1804 publishes the protocol within the library such that the protocol is visible to user software accessing the library when it resides within the database 504 of
The parameter user interface 1800 further includes a number of tabs, including a drug delivery tab 1810, a secondary drug delivery tab 1820, an alarm tab 1830, a security tab 1840, a display/sound tab 1850, and a report tab 1860. Parameters set within each of the tabs are discussed in
The general settings region 1812 includes verification settings 1816 and weight based settings 1818. The verification settings 1816 includes drug verification and caregiver verification settings. Specifically, the verification settings require that a caregiver verifies that the correct drug is provided to the medical infusion pump. The verification settings also require a second caregiver to verify the settings of the medical infusion pump. The weight based settings 1818 set a weight based protocol at a programmable, variable weight limit. By weight based protocol, it is intended that dosage delivery rates, boluses, thresholds, and other delivery parameters change from a “dosage per hour” basis to a “dosage per weight factor” rate, where the weight factor can be on a per unit measure weight basis for the user of the medical infusion pump 102 (i.e. “per kilogram” or other), or based on the user's body surface area, a weight based therapy, or other options.
The patient specific parameters region 1814 includes a continuous rate region 1822, a demand dose region 1824, and a demand dose lockout region 1826. Continuous rate refers to the constant drug delivery rate of the medical infusion pump, also referred to as the basal rate. Demand dose refers to an added drug delivery bolus amount delivered by the pump upon a demand by a patient. Demand dose lockout refers to the time interval after a demand dose is delivered, during which another demand dose will not be delivered by the pump.
The continuous rate region 1822 includes a meter, shown as a slider bar 1828 and an indicator 1829. The meter generally has two or more locations, each corresponding to a parameter value that can be programmed in the medical infusion pump. Generally, the positional relationship of the meter indicates the setting of the meter. In a possible embodiment of the slider bar 1828 shown, the indicator 1829 is movable relative to the slider bar 1828 to set a default value, or “initial value” continuous drug delivery rate parameter. In a second possible embodiment, the default value is set using an initial value gauge 1832.
The continuous rate region also includes hard limit gauges 1834, soft limit gauges 1836, and user interface options 1838a-1838c. The initial value gauge 1832, hard limit gauges 1834, and soft limit gauges 1836 include values, which may include numerical ranges. The hard limit gauges 1834 set a hard maximum and hard minimum which form an acceptable pump programming range. The range of acceptable pump activity represents the absolute maximum and minimum values programmable into the pump by user software, as described below. This configuration allows for control of the range of values visible to a user of the medical infusion pump or associated computing system.
The limits set by the soft limit gauges 1836 represent a manually exceedable threshold value. The soft limit can be overridden by a user of a medical infusion pump on a pump-by-pump basis. Pump activity outside the range defined by soft limits can trigger an alarm or otherwise alert a caregiver that a pump is functioning outside of the usual operational range of the pump. A variety of alarm levels or alerts can be set by the soft limit gauges 1836. For example, the alert can be a flag set in the software. The alert could additionally be an audible alarm, or a visual indicator displayed on at least a portion of the medical infusion pump. The visual indicator could be a flashing indicator or changed/changing color on the display of the medical infusion pump.
In a second possible embodiment, the hard limit gauges set a non-limiting range, and the user software described below can be programmed within its full operational range. In such an embodiment, pump activity outside the range set by the hard limit gauges 1834 can trigger an alarm or otherwise alert a caregiver that a pump is functioning outside of the usual operational range of the pump. In this embodiment, the soft limit gauges 1836 set a narrower range, operation outside of which can trigger a warning or second alarm indicating pump activity outside of an expected range of pump operation. This warning or second alarm indicates a pump condition less serious than the alarm triggered by the hard limits.
The user interface options 1838a-1838c enable the user software to display and edit the delivery rate, editing of the delivery rate, and requiring comments by users of a pump who wish to exceed the soft limits when setting the drug delivery rate. Selection of the display option 1838a publishes the pump parameter so that the value is visible to a user of the pump or computing system.
The demand dose region 1824 includes a slider bar 1842 and an indicator 1843. The slider bar and indicator operate in a similar manner to the slider bar 1828 and indicator 1829 in the continuous rate region 1822, but control demand dose settings. Likewise, the demand dose region 1824 includes an initial value gauge 1844, as well as hard limit gauges 1846 and soft limit gauges 1848 setting visible thresholds and triggering alarms as in the continuous rate region 1822. Demand dose options 1852a-1852c provide analogous display, editing, and comment options to the user interface options 1838a-1838c.
The demand dose lockout region 1826 includes a slider bar 1854 and an indicator 1855, and also includes an initial value gauge 1856, hard limit gauges 1858, and soft limit gauges 1862. Each of these features functions analogously to those discussed above in conjunction with the continuous rate region 1822. The demand dose lockout region also includes lockout options 1864a-1864c analogous to the user interface options 1838a-1838c.
The dosing limit region 2002 displays limits for total drug delivery within a specified amount of time. The dosing limit region 2002 includes options for setting a limit on doses per hour, a timed medication delivery limit, or other limits. A user selects one of the options for setting the dosage limit.
The patient specific parameter region 2004 sets parameters related to the dosage limits coordinated to the options in the dosing limit region 2002. The patient specific parameter region 1804 includes a timed delivery limit region 2012, an hourly demand doses region 2014, and a reservoir region 2016.
The timed delivery limit region 2012 sets the delivery limit on a per assigned time period when the option for setting a limit on doses per hour is selected in the dosing limit region 2002. The timed delivery limit region 2012 includes a meter, shown as a slider bar 2018 and indicator 2019. The timed delivery limit region 2012 also includes an initial value gauge 2020, hard limit gauges 2022, soft limit gauges 2024, and control options 2026a-2026c. Operation of the slider bar 2018, indicator 2019, gauges 2020-2024, and control options 2026a-2026c is analogous to operation of the slider bar features as discussed in conjunction with
The hourly demand doses region 2014 sets the delivery limit on a per hour basis when the doses per hour limit is selected in the dosing limit region 2002. The maximum demand doses region 2014 includes a slider bar 2028, indicator 2029, gauges 2030-2034, and control options 2036a-2036c, operation of which is likewise analogous to operation of the slider bar features discussed in
The timed delivery limit region 2012 and hourly demand doses region 2014 are operated in the alternative, in that only one of the two regions is active at one time. The region that is active depends upon the option selected in the dosing limit region 2002. Selection of a timed delivery limit in the dosing limit region 2002 activates the timed delivery limit region 2012 and deactivates the hourly demand doses region 2014. Selection of an hourly delivery limit activates the hourly demand doses region 2014 and deactivates the timed delivery limit region 2012.
The reservoir region 2016 sets the initial volume settings and display settings for tracking the volume of fluid in the reservoir attached to the medical infusion pump. The reservoir region 2016 includes a meter, shown as a slider bar 2040 and indicator 2041, operation of which is analogous to the slider bar and indicator discussed in conjunction with
The remaining regions, i.e. the titration region 2006, the maximum deliver rate gauge 2008, and the maximum clinician bolus gauge 2010, set pump specific settings related to drug delivery limits. The titration region 2006 enables or disables titration in the medical infusion pump, and sets an optional titration limit in the pump. The maximum delivery rate gauge 2008 sets a maximum delivery rate for the infusion pump. The maximum delivery rate is measured in milliliters per hour, and includes both the basal delivery rate and bolus delivery. The maximum clinician bolus gauge 2010 sets the maximum bolus which can be delivered by a caregiver. The maximum clinician bolus may be a larger bolus than the standard patient-controlled bolus, but must be administered under the supervision of a caregiver. Other regions can be included in the tab 1820 as well.
Referring now to
The above description and figures corresponding to the administrative software 700 provides a therapy-centric programming schema for a medical infusion pump. For example, a certain drug used in conjunction with a medical infusion pump may be appropriate for use with a specific therapy for an adult, but may not be appropriate for the same therapy for a child. Certain drugs may only be appropriate in certain therapies, and under certain qualifying conditions. Pump parameters are initially set according to the protocols defined in the administrative software 700, but are customizable on a pump-by-pump basis using user software associated with a specific pump and/or patient.
The medical infusion pumps as described store pump data in memory, such as the memory shown above in
The user software 2600 is instantiated by a start module 2602. The start module 2602 corresponds to initial execution of the user software 2600 by clicking on an icon on the computer or by some other mechanism for executing software. Upon execution of the start module 2602, the user software 2600 connects to a library on a server 206 containing one or more pump protocols.
Following the start module 2602, operational flow optionally proceeds to a library import module 2604. The library import module 2606 provides the ability to import one or more libraries into the software 2600. This feature can be used by a computing system 104 or medical infusion pump 102 that is not connected to the same medical infusion pump network 500 as the database storing the library 504. If the computing system 104 or medical infusion pump 102 is connected to the medical infusion pump network 500, each component is by default connected to the server 206 and database 504.
The libraries available to be imported include pump protocols and parameters, and may have been created using the administrative software of
Once connected to the desired library either by default or via the library import module 2604, operational flow proceeds to a login module 2606. The login module 2606 regulates user rights in the software 2600 by controlling access to the libraries 508 in the database 504 of
Different access levels also can provide different rights with respect to pump operational parameters. For example, one access level might give a user a right to edit patient specific pump parameters. One access level might permit a user the right to only view and download the patient specific pump operational parameters. Different embodiments can include the ability to provide an access level for a user any combination of rights to edit, view, and/or download pump operational parameters, protocols, or libraries.
Once the user is logged in, the user selectively executes three different modules, a protocol selection module 2608, a task module 2610, and a report module 2612.
The protocol selection module 2608 selects a protocol for use with a medical infusion pump from the protocols loaded in the user software 2600. The protocol selection module 2608 guides the user through selection of a therapy, qualifier, and drug combination defined to be a protocol by the administrative software. The protocol selection module 2608 includes a therapy selection module 2614, a qualifier selection module 2616, and a drug selection module 2618 for this purpose. The therapy selection module 2416 selects a therapy to be administered by the drug infusion pump 102. The therapy is one of the therapies included in the library selected in the library import module 2606. The qualifier selection module 2616 selects a qualifier from those associated with the therapy in the library. The drug selection module 2618 selects a drug associated with the therapy and drug. The protocol selection module 2608 further allows customization of the protocol by allowing a user to modify pump parameters, such as the drug delivery rate, the demand dose, the demand dose lockout, drug delivery limits, and reservoir volume.
The task module 2610 guides a user through maintenance and monitoring tasks that are required for each medical infusion pump 102. These maintenance and monitoring tasks can include pump settings comparison and testing, as well as changing the reservoir holding the drug delivered by the medical infusion pump 102. The task module 2610 includes a pump settings module 2620, a comparison module 2622, and a reservoir module 2624. The pump settings module 2620 compares the local pump settings to a standing order set for the pump, for example by a caregiver who programmed or customized the medical infusion pump. During operation of the pump settings module 2620, the user software 2600 receives a GUID specific to a protocol and generated by the server 206, and stores the GUID on the pump or computing system. The GUID generated by the server and stored on the pump or computing system is made available to the server when the pump or computing system accesses the library to look up and verify the future access of the correct protocol and/or library. This ensures that the pump settings are compared to the correct protocol stored on the server. The comparison module 2622 compares the local pump settings to a protocol, such as the protocols defined using the administrative software 700. The reservoir module 2624 determines if a drug reservoir is nearly empty and guides a patient or caregiver through the drug cartridge changing process occasionally required during use of a medical infusion pump.
The report module 2612 generates a report from preexisting logged information for a selected medical infusion pump 102. The report module includes a location module 2626 and a type module 2628. The location module 2626 requests the location of the pump from which a report is generated, such as a specific pump or a previously saved report stored on the pump or computing system. The type module 2628 presents a number of types of reports which can be generated from the logged information, such as a drug delivery report or event log, and can display the report responsive to a user request.
Operation of the software terminates at an end module 2630. The end module 2630 corresponds to termination of the administrative software 2600 by clicking on a close window button on the computer or by some other mechanism for terminating execution of software.
Referring to
Following the start module 2802, operational flow proceeds to a load protocols module 2804. The load protocols module 2804 populates the user software 2600 with the protocols from the loaded library. For example, the load protocols module 2804 can populate a listing of protocols for selection using the user software 2600.
Following the load protocols module 2804, operational flow proceeds to a select protocol module 2806. The select protocol module 2806 selects a protocol from among the protocols loaded into the user software 2600 by guiding a user through selection of a therapy, qualifier, and drug defining one of the protocols loaded in the software 2600. The select protocol module 2806 corresponds to the therapy selection module 2614, qualifier selection module 2616, and drug selection module 2618 shown in
Following the select protocol module 2806, operational flow proceeds to a settings module 2808. The settings module 2808 provides editing and customization of the pump parameters assigned to a medical infusion pump as dictated by the protocol selected by the user. The parameters include, for example, the drug delivery rate, demand dose rate, or demand dose lockout.
Following the settings module 2808, operational flow proceeds to an optional pump programming module 2810. The pump programming module 2810 programs a medical infusion pump with the settings both as defined by the protocol and selected by the select protocol module 2806, and as customized by the settings module 2808. The pump programming module 2810 executes if the user software 2600 resides on a computing system 104 connected to a medical infusion pump 102. The pump programming module may not execute if the software 2600 resides on the medical infusion pump 102 itself, because the protocols are already loaded into the pump alongside the library accessed by the user software 2600.
After the pump programming module 2810 completes, operation of the protocol selection module 2608 terminates at an end module 2812. The end module 2812 corresponds to successful programming of the medical infusion pump.
The login button 2902, when selected, generates a login screen that checks whether a user has the right to access pump programs, protocols, or parameters. The connection status indicator 2904 displays the connection status of the user software. Connection status can include a connection to a medical infusion pump or connection to a networked server. The library indicator 2906 displays the current library loaded using the library import screen 2700 of
Referring now to
The therapy selection field 2908 lists the therapies included in the currently loaded library. For example, the two therapies shown are “Epidural” and “Patient Controlled Analgesia”. The therapy notes field displays the notes associated with the selected therapy. In the initial state, the therapy selection field 2908 and therapy notes field 2910 are active, and the qualifier fields 2912, 2914, drug fields 2916, 2918, and continue button 2922 are inactive. No therapy is initially selected in the therapy listing field 2908, so the therapy notes field 2910 remains empty.
The settings module 2608 is instantiated by a start module 3302. The start module 3302 corresponds to selection of the confirmation button 2922 of
Following the start module 3302, operational flow proceeds to a display module 3304. The display module 3304 displays the default protocol settings of the protocol loaded onto a medical infusion pump screen or a computing system associated with the pump. The display module 3304 presents a number of meters to a user related to the drug delivery rates and other parameters controlled by the pump. The meters provide user controls for modifying one or more pump parameters.
In various embodiments, the display module 3304 can be configured to display a variety of coloring and image features. In one possible embodiment, the meters are slider bars that can include graphical thresholds set by the administrative software. A cautionary color change of the user interface (i.e. green or gray to yellow or red) can represent a warning to the user that the current setting is outside of the administratively set thresholds.
In another possible embodiment, the overall background color of the user interface is color-coded to correspond to hospital coding procedures, and can represent one or more location-specific warning or status conditions. Additionally, the color coding can be located behind an image displayed on the pump screen, and can be keyed to a location of the medical infusion pump, the drug administered, or a warning condition within the pump.
Following the display module 3304, operational flow proceeds to a custom settings module 3306. The custom settings module 3306 receives the current customized pump settings based on user-customization of one or more pump parameters. The custom settings module 3306 can provide a user customization interface for setting pump parameters to values other than the initial or default values set in the administrative software 700.
Following the custom settings module 3306, operational flow depends upon the implementation of the hard limits and soft limits in the administrative software 700. If the hard limit gauges in
The optional hard limit determination operation 3308 determines if the pump settings are outside the “hard limits” set in the administrative software 700. If the pump settings exceed the hard limit (i.e. above the maximum or below the minimum value), operational flow branches “yes” to a hard limit indicator module 3310. If the pump settings do not exceed the hard limit, operational flow branches “no” to a soft limit determination operation 3312.
The optional hard limit indicator module 3310 executes in conjunction with the hard limit determination operation 3308, and generates an indicator to a user that the hard limit set in the administrative software is exceeded by the current settings of the medical infusion pump. If the hard limit determination operation 3308 is bypassed or otherwise absent from the user software 2600, the hard limit indicator module 3310 can be absent/bypassed as well. The hard limit indicator module 3310 creates an alert indicator on the display of the pump or associated computing system, or sends an alert to the server or other computing system to alert a caregiver that an alert condition has been reached by the pump due to exceeding the hard limit. Operational flow proceeds to the display module 3704 to update the display and to allow additional user modification of the pump settings.
The soft limit determination operation 3312 determines if the pump settings are outside the “soft limits” set in the administrative software 700. If the pump settings exceed the soft limit, operational flow branches “yes” to a soft limit indicator module 3314. If the pump settings do not exceed the soft limit, operational flow branches “no” to return to the display module 3304.
The soft limit indicator module 3314 generates an indicator to a user that the soft limit set in the administrative software is exceeded by the current parameter settings. The soft limit indicator module 3314 creates an alert indicator different from the hard limit indicator module 3310 if the hard limit indicator module 3310 exists or executes within the software 2600. For example, the soft limit alert indicator can be a different color, display a different message, or send a different alert to a remote medical care provider.
Following the soft limit indicator module 3314, operational flow proceeds to the display module 3304 to update the display and allow additional user modifications of the pump settings. Upon termination of operation of the medical infusion pump, operational flow terminates at the end module 3316.
Referring now to
The regions 3404-3412 correspond to the patient specific pump parameters 512a of
The user interface 3400 presents a standardized interface to a patient or caregiver using the user software 2600, such as at the point of care of a patient or other location on the infusion pump network. The user interface 2600 corresponds to any of a number of types of user software 2600 and administrative software 700. The user interface 3400 also can be configured to be used with various types of medical infusion pumps 102. Most pumps require programming with both patient specific pump parameters and non-patient specific pump parameters, but vary as to the data structure in which this data is passed to the pump. The user interface 3400 reflects from the user software 2600 the number of regions to create corresponding to the number of patient specific pump parameters, which are generic to various types of pumps. Therefore, the user interface 3400 can be used with any of a number of pumps having various brands, interfaces, data structures, or other variances.
The status indicator 3402 displays the library, therapy, qualifier, and drug which define the protocol loaded by the user software 2600. In the exemplary user interface, the library is an “ICU” library, the therapy selected is “Patient Controlled Analgesia”, the qualifier is “Adult and Child over 5”, and the drug is “Fentanyl 10 mcg/ml”.
The continuous rate region 3404 defines the continuous, or basal, rate of drug delivery in the specific medical infusion pump. The continuous rate region 3404 includes a numerical reading 3416 and a meter, shown as a slider bar 3418 and an indicator 3419. The meter generally has two or more locations, each corresponding to a parameter value that can be programmed in the medical infusion pump. Generally, the positional relationship of the meter indicates the setting of the meter. The numerical reading 3416 reflects the current value for the continuous drug delivery rate.
In the embodiment of the meter shown as the slider bar 3418, the indicator 3419 slides along the slider bar 3418, and the positional relationship between the slider bar 3418 and indicator 3419 dictates the continuous drug delivery rate. Threshold indicators 3420 determine the safe limits within which the continuous rate can be set, and can represent either the hard limits or the soft limits set for the parameter by the administrative software 700. In the embodiment of the user software 2600 whose absolute threshold levels are limited by the hard limits set in the administrative software 700, the ends of each bar 3418 represent the hard limits and the threshold indicators 3420 represent the soft limits for the continuous rate. The thresholds are tested using the method described in
The demand dose region 3406 customizes the demand dose, or bolus, delivered by the medical infusion pump. The demand dose region includes a numerical reading 3422 and a meter, shown as a slider bar 3424 and indicator 3425. The slider bar 3424 includes threshold indicators 3426 displaying either the hard or soft limit defined in the administrative software. The numerical reading 3422, slider bar 3424, indicator 3425, and threshold indicators 3426 operate analogously to those in the continuous rate region 3404, but set the bolus level parameter rather than the continuous rate parameter.
The demand dose lockout region 3408 customizes the time period after a bolus is delivered in which no additional bolus can be provided. The demand dose lockout region 3408 includes a numerical reading 3428 and a meter, shown as a slider bar 3430 and indicator 3431. The slider bar 3430 includes threshold indicators 3432 displaying either the hard or soft limit defined in the administrative software. The numerical reading 3428, slider bar 3430, indicator 3431, and threshold indicators 3432 operate analogously to those in the continuous rate region 3404, but set the demand dose lockout period parameter rather than the continuous rate parameter.
The timed limit region 3410 customizes the amount of the selected drug deliverable by a medical infusion pump within a specified timeframe. The timed limit region 3410 also includes a numerical reading 3434 and a meter, shown as a slider bar 3436 and indicator 3437. The slider bar 3436 includes threshold indicators 3438 displaying either the hard or soft limit defined in the administrative software. The numerical reading 3434, slider bar 3436, indicator 3437, and threshold indicators 3438 operate analogously to those in the continuous rate region 3404, but set the timed drug delivery threshold parameter rather than the continuous rate parameter.
The reservoir region 3412 defines the size of the reservoir used in conjunction with the medical infusion pump. The size of the reservoir is relevant to computing drug delivery volumes for the purpose of setting alarms and other indicators for replacing or refilling the reservoir. The reservoir region 3412, like the other regions, includes a numerical reading 3440 and a meter, shown as a slider bar 3442 and indicator 3443. The slider bar 3442 includes threshold indicators 3444 displaying either the hard or soft limit defined in the administrative software. The numerical reading 3440, slider bar 3442, and indicator 3443 operate analogously to those in the continuous rate region 3404, but set the reservoir volume parameter rather than the continuous rate parameter. In the embodiment shown, no threshold indicators are included in the reservoir region. This is because the reservoir region 3412 is allowed to use the entire operational range of the reservoir, since no hard limits are set in the reservoir volume region 2016 of
The meters in each region 3404-3412 may be adjustable in that each of the patient specific pump parameters are adjustable using a meter. The administrative software 700 enables the adjustment of one or more of the meters by allowing adjustment of those patient specific pump parameters using the options displayed on the user interface 1800 of
The control buttons 3414a-3414c allow a user to send the currently set parameters to the associated medical infusion pump, cancel the parameter customization, or receive help in the process.
It is noted that additional screen coloration or textual messages can be used to graphically send messages to a user or programmer of the medical infusion pump or associated computing system. For example, a color code system can be used to reflect a variety of conditions of the medical infusion pump. For example, a color could represent the current coding of the hospital or other health care facility at which the pump may be located. Additionally, the color code can represent a warning condition, a location at which the pump is used, a drug being administered by the pump, or an alert condition. Of course, the color code could represent additional characteristics of the medical infusion pump as well.
The color code can display on the computing system associated with the medical infusion pump, or can be reflected on a monitor associated to the medical infusion pump itself. Text messages can be sent from the server to be displayed on the monitor of the pump or computing system, such as warnings regarding medication, usage tips for the medical infusion pump, or other medical advice. Additionally, the color code can be placed behind images displayed on the pump which can also represent a region of the hospital, an image of the drug being administered, or other background images. Additionally, the screen coloration described can be represented as a flashing screen, a color changing (cross-fading or otherwise) screen, or various other color patterns.
The settings 3602a-3602e reflect the customized pump parameters set using the user interface 3600 of
The protocol indicator field 3604 displays the current protocol selected, in this case shown as “Patient Controlled Analgesia”, “Adult and Child over 5”, and “Fentanyl 10 mcg/ml”. The confirmation button 3606 sends the pump program, including the settings 3602a-3602e for the pump parameters, to the pump.
Once the pump is programmed, the pump program executes according to the protocol selected in conjunction with the customized parameters. Referring now to
Customizations in protocol programming refer to differences between the actual pump operation and a standing order (i.e. settings programmed by an administrative user). The standing order can be an original pump parameter or initial value, and the pump operation for comparison can be either a current pump parameter or simply a non-original pump parameter.
A start module 3702 initiates the process 3700. Operational flow proceeds to a comparison module, shown as a compare pump settings to standing order module 3704. The pump settings stored on the pump or computing system as shown above in
In one possible embodiment, a legend can indicate the meaning of the pump parameters being displayed, and a time/date stamp can display the time at which the original and/or non-original pump parameter was measured. In additional embodiments, differences between the original and non-original pump parameters can be highlighted when displayed, such as by using a color change or other indicator.
Operational flow terminates at an end module 3708.
The change bar 3800 includes a plurality of change bar entries 3802. The change bar entries correspond to pump parameters, and in the figure shown the entries 3802a-3802b correspond to patient specific pump parameters. The change bar can display non patient specific pump parameters as well.
The change bar 3800 can compare any of a number of original and non-original pump parameters. In one embodiment, the change bar 3800 compares the current operation of the pump to the originally programmed operation of the pump. In another embodiment, the change bar 3800 compares the operation of the pump as initially programmed to the suggested programming of the pump based on the original pump protocol. In a further embodiment, the change bar 3800 compares historical activity of the pump to the current pump protocol.
In one embodiment of the change bar 3800, the change bar entries 3802a-3802b change color when the difference between the original and the non-original pump parameters exceeds a threshold amount. The threshold amount can be, for example, the soft limits set in the administrative software 700. In a further embodiment, the text can change color when a difference greater than the threshold is detected. The change bar can incorporate additional graphics and images on the display.
Referring now to
The user software 2600 accesses the protocol loaded on the server 206 to compare the current pump settings to the original or current protocol using the options 3904, 3906. To accomplish this, it is necessary for the user software 2600 to clarify to the server 206 which protocol is being compared within the database 504 of
The change reservoir option 3910 guides a user of the software 2600 through changing a drug reservoir used in conjunction with the medical infusion pump.
Aspects of the invention described as being carried out by a computing system or otherwise described as a method of control or manipulation of data may be implemented in one or a combination of hardware, firmware, and software. Embodiments of the invention may also be implemented as instructions stored on a machine-readable medium, which may be read and executed by at least one processor to perform the operations described herein. A machine-readable medium may include any mechanism for storing or transmitting information in a form readable by a machine (e.g., a computer). For example, a machine-readable medium may include read-only memory (ROM), random-access memory (RAM), magnetic disc storage media, optical storage media, flash-memory devices, electrical, optical, acoustical or other form of propagated signals (e.g., carrier waves, infrared signals, digital signals, etc.), and others.
In the foregoing detailed description, various features are occasionally grouped together in a single embodiment for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the claimed embodiments of the subject matter require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment. Thus, the following claims are hereby incorporated into the detailed description, with each claim standing on its own as a separate preferred embodiment. Therefore, the spirit and scope of the appended claims should not be limited to the description of the preferred versions contained herein.
This application is a continuation of application Ser. No. 13/419,138 filed Mar. 13, 2012, now U.S. Pat. No. 8,952,794, issued Feb. 10, 2015, which in turn is a continuation of application Ser. No. 11/499,255 filed Aug. 3, 2006, now U.S. Pat. No. 8,149,131 issued Apr. 3, 2012, each of which is hereby fully incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2968804 | Buffington | Jan 1961 | A |
3555286 | Cote | Jan 1971 | A |
3603152 | Alibert et al. | Sep 1971 | A |
3777165 | Bryant et al. | Dec 1973 | A |
3809871 | Howard et al. | May 1974 | A |
3923060 | Ellinwood, Jr. | Dec 1975 | A |
3942526 | Wilder et al. | Mar 1976 | A |
3985133 | Jenkins et al. | Oct 1976 | A |
4027536 | Heggie | Jun 1977 | A |
T961004 | Horton | Aug 1977 | I4 |
4080967 | O'Leary | Mar 1978 | A |
4091550 | Schrenk et al. | May 1978 | A |
4098267 | Stein et al. | Jul 1978 | A |
4137913 | Georgi | Feb 1979 | A |
4141252 | Lodge | Feb 1979 | A |
4146029 | Ellinwood, Jr. | Mar 1979 | A |
4174637 | Mulzet et al. | Nov 1979 | A |
4184815 | Casson et al. | Jan 1980 | A |
4191184 | Carlisle | Mar 1980 | A |
4210138 | Jess et al. | Jul 1980 | A |
4213454 | Shim | Jul 1980 | A |
4217993 | Jess et al. | Aug 1980 | A |
4236880 | Archibald | Dec 1980 | A |
4270532 | Franetzki et al. | Jun 1981 | A |
4279188 | Scott | Jul 1981 | A |
4280136 | Kashima et al. | Jul 1981 | A |
4282872 | Franetzki et al. | Aug 1981 | A |
4299218 | Knigge et al. | Nov 1981 | A |
4299541 | Ohara et al. | Nov 1981 | A |
4308866 | Jelliffe et al. | Jan 1982 | A |
4309993 | Brown | Jan 1982 | A |
4311377 | Matteson | Jan 1982 | A |
4314227 | Eventoff | Feb 1982 | A |
4314228 | Eventoff | Feb 1982 | A |
4315238 | Eventoff | Feb 1982 | A |
4320757 | Whitney et al. | Mar 1982 | A |
4368645 | Glenn et al. | Jan 1983 | A |
4369780 | Sakai | Jan 1983 | A |
4370983 | Lichtenstein | Feb 1983 | A |
4373525 | Kobayashi | Feb 1983 | A |
4373527 | Fischell | Feb 1983 | A |
4385630 | Gilcher et al. | May 1983 | A |
4385958 | Long | May 1983 | A |
RE31315 | Jenkins et al. | Jul 1983 | E |
4392849 | Petre et al. | Jul 1983 | A |
4394862 | Shim | Jul 1983 | A |
4395259 | Prestele et al. | Jul 1983 | A |
4396977 | Slater et al. | Aug 1983 | A |
4398542 | Cunningham et al. | Aug 1983 | A |
4410322 | Archibald | Oct 1983 | A |
4413314 | Slater et al. | Nov 1983 | A |
4425661 | Moses et al. | Jan 1984 | A |
4431425 | Thompson et al. | Feb 1984 | A |
4443218 | DeCant, Jr. et al. | Apr 1984 | A |
4446344 | Fiedler | May 1984 | A |
4460355 | Layman | Jul 1984 | A |
4484479 | Eckhardt | Nov 1984 | A |
4489302 | Eventoff | Dec 1984 | A |
4490798 | Franks et al. | Dec 1984 | A |
4493704 | Beard et al. | Jan 1985 | A |
4494950 | Fischell | Jan 1985 | A |
4498843 | Schneider et al. | Feb 1985 | A |
4512013 | Nash et al. | Apr 1985 | A |
4520706 | Deforeit | Jun 1985 | A |
4526574 | Pekkarinen | Jul 1985 | A |
4529401 | Leslie et al. | Jul 1985 | A |
4530696 | Bisera et al. | Jul 1985 | A |
4534756 | Nelson | Aug 1985 | A |
4542532 | McQuilkin | Sep 1985 | A |
4550731 | Batina et al. | Nov 1985 | A |
4550748 | Nunez | Nov 1985 | A |
4557725 | Heyne et al. | Dec 1985 | A |
4559037 | Franetzki et al. | Dec 1985 | A |
4559038 | Berg et al. | Dec 1985 | A |
4559044 | Robinson et al. | Dec 1985 | A |
4561443 | Hogrefe | Dec 1985 | A |
4562751 | Nason et al. | Jan 1986 | A |
4563179 | Sakai | Jan 1986 | A |
4565542 | Berg | Jan 1986 | A |
4578573 | Flies et al. | Mar 1986 | A |
4596575 | Rosenberg et al. | Jun 1986 | A |
4597754 | Thill et al. | Jul 1986 | A |
4601702 | Hudson | Jul 1986 | A |
4606353 | Timm | Aug 1986 | A |
4617014 | Cannon et al. | Oct 1986 | A |
4623331 | Cewers et al. | Nov 1986 | A |
4624661 | Arimond | Nov 1986 | A |
4627835 | Fenton, Jr. | Dec 1986 | A |
4627839 | Young | Dec 1986 | A |
4649499 | Sutton et al. | Mar 1987 | A |
4650469 | Berg et al. | Mar 1987 | A |
4652260 | Fenton, Jr. | Mar 1987 | A |
4656603 | Dunn | Apr 1987 | A |
4658371 | Walsh et al. | Apr 1987 | A |
4671792 | Borsanyi | Jun 1987 | A |
4676776 | Hawson | Jun 1987 | A |
4678408 | Nason et al. | Jul 1987 | A |
4681563 | Deckert et al. | Jul 1987 | A |
4685903 | Cable et al. | Aug 1987 | A |
4690673 | Bloomquist | Sep 1987 | A |
4692147 | Duggan | Sep 1987 | A |
4696671 | Epstein et al. | Sep 1987 | A |
4710163 | Butterfield | Dec 1987 | A |
4714462 | DiDomenico | Dec 1987 | A |
4722734 | Kollin | Feb 1988 | A |
D294733 | Peterson et al. | Mar 1988 | S |
4731051 | Fischell | Mar 1988 | A |
4731058 | Doan | Mar 1988 | A |
4731726 | Allen | Mar 1988 | A |
4739229 | Heiler, Jr. | Apr 1988 | A |
4741732 | Crankshaw et al. | May 1988 | A |
4745301 | Michalchik | May 1988 | A |
4747828 | Tseo | May 1988 | A |
4754401 | Kaczynski et al. | Jun 1988 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4774029 | Poulin | Sep 1988 | A |
4775368 | Iwatschenko | Oct 1988 | A |
4778449 | Weber et al. | Oct 1988 | A |
4785799 | Schoon et al. | Nov 1988 | A |
4790816 | Sundblom et al. | Dec 1988 | A |
4799381 | Tromp | Jan 1989 | A |
4808161 | Karmen | Feb 1989 | A |
4808167 | Mann et al. | Feb 1989 | A |
4809697 | Causey, III et al. | Mar 1989 | A |
4810243 | Howson | Mar 1989 | A |
4810992 | Eventoff | Mar 1989 | A |
4816019 | Karmen | Mar 1989 | A |
4818186 | Pastrone et al. | Apr 1989 | A |
4826810 | Aoki | May 1989 | A |
4832033 | Maher et al. | May 1989 | A |
4836752 | Burkett | Jun 1989 | A |
4838856 | Mulreany et al. | Jun 1989 | A |
4838857 | Strowe et al. | Jun 1989 | A |
4842584 | Pastrone | Jun 1989 | A |
4846792 | Bobo, Jr. et al. | Jul 1989 | A |
4847764 | Halvorson | Jul 1989 | A |
4847990 | Patrick | Jul 1989 | A |
4850807 | Frantz | Jul 1989 | A |
4850972 | Schulman et al. | Jul 1989 | A |
4852581 | Frank | Aug 1989 | A |
4854324 | Hirschman et al. | Aug 1989 | A |
4856339 | Williams | Aug 1989 | A |
4863425 | Slate et al. | Sep 1989 | A |
4869722 | Heyman | Sep 1989 | A |
4871351 | Feingold | Oct 1989 | A |
4878896 | Garrison et al. | Nov 1989 | A |
4882575 | Kawahara | Nov 1989 | A |
4889132 | Hutcheson et al. | Dec 1989 | A |
4898578 | Rubalcaba, Jr. | Feb 1990 | A |
4901221 | Kodosky et al. | Feb 1990 | A |
4908017 | Howson et al. | Mar 1990 | A |
4914568 | Kodosky et al. | Apr 1990 | A |
4918930 | Gaudet et al. | Apr 1990 | A |
4919650 | Feingold et al. | Apr 1990 | A |
4925444 | Orkin et al. | May 1990 | A |
4927411 | Pastrone et al. | May 1990 | A |
4933873 | Kaufman et al. | Jun 1990 | A |
4942514 | Miyagaki et al. | Jul 1990 | A |
4943279 | Samiotes et al. | Jul 1990 | A |
4950235 | Slate et al. | Aug 1990 | A |
4950244 | Fellingham et al. | Aug 1990 | A |
4954818 | Nakang et al. | Sep 1990 | A |
4957690 | Fennern | Sep 1990 | A |
4961533 | Teller et al. | Oct 1990 | A |
4970664 | Kaiser | Nov 1990 | A |
4976151 | Morishita | Dec 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
4979940 | Bobo, Jr. et al. | Dec 1990 | A |
4994035 | Mokros | Feb 1991 | A |
4996511 | Ohkawa et al. | Feb 1991 | A |
5000739 | Kulisz et al. | Mar 1991 | A |
5006997 | Reich | Apr 1991 | A |
5009641 | Gorton | Apr 1991 | A |
5010473 | Jacobs | Apr 1991 | A |
5017059 | Davis | May 1991 | A |
5032978 | Watson et al. | Jul 1991 | A |
5034004 | Crankshaw | Jul 1991 | A |
5038800 | Oba | Aug 1991 | A |
5041086 | Koenig et al. | Aug 1991 | A |
5045069 | Imparato | Sep 1991 | A |
5047014 | Mosebach et al. | Sep 1991 | A |
5050612 | Matsumura | Sep 1991 | A |
5053585 | Yaniger | Oct 1991 | A |
5053990 | Kreifels | Oct 1991 | A |
5062774 | Kramer et al. | Nov 1991 | A |
5069668 | Boydman | Dec 1991 | A |
5074756 | Davis | Dec 1991 | A |
5078682 | Miki et al. | Jan 1992 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5082014 | Olichney | Jan 1992 | A |
5084828 | Kaufman et al. | Jan 1992 | A |
5087245 | Doan | Feb 1992 | A |
5088983 | Burke | Feb 1992 | A |
5096385 | Georgi et al. | Mar 1992 | A |
5098262 | Wecker et al. | Mar 1992 | A |
5098409 | Stock | Mar 1992 | A |
5100380 | Epstein et al. | Mar 1992 | A |
5103211 | Daoud et al. | Apr 1992 | A |
5104374 | Bishko et al. | Apr 1992 | A |
5111234 | Taniguchi et al. | May 1992 | A |
5115223 | Moody | May 1992 | A |
5116312 | Blankenship et al. | May 1992 | A |
5122820 | Pagano et al. | Jun 1992 | A |
5124744 | Ogura et al. | Jun 1992 | A |
5124802 | Ito et al. | Jun 1992 | A |
5131816 | Brown et al. | Jul 1992 | A |
5140862 | Pappalardo | Aug 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5154700 | Danby | Oct 1992 | A |
5155693 | Altmayer et al. | Oct 1992 | A |
5157928 | Gaudet et al. | Oct 1992 | A |
5168441 | Onarheim et al. | Dec 1992 | A |
5172698 | Stanko | Dec 1992 | A |
5174472 | Raque et al. | Dec 1992 | A |
5176004 | Gaudet | Jan 1993 | A |
5181910 | Scanlon | Jan 1993 | A |
5190442 | Jorritsma | Mar 1993 | A |
5190522 | Wojcicki et al. | Mar 1993 | A |
5207642 | Orkin et al. | May 1993 | A |
5211626 | Frank et al. | May 1993 | A |
5213573 | Hyman et al. | Jun 1993 | A |
5217355 | Hyman et al. | Jun 1993 | A |
5219327 | Okada | Jun 1993 | A |
5221268 | Barton et al. | Jun 1993 | A |
5224051 | Johnson | Jun 1993 | A |
5230623 | Guthrie et al. | Jul 1993 | A |
5238001 | Gallant et al. | Aug 1993 | A |
5241461 | Georges | Aug 1993 | A |
5244461 | Derlien | Sep 1993 | A |
5244463 | Cordner, Jr. et al. | Sep 1993 | A |
5247434 | Peterson et al. | Sep 1993 | A |
5256157 | Samiotes et al. | Oct 1993 | A |
5265431 | Gaudet et al. | Nov 1993 | A |
5267218 | Elbert | Nov 1993 | A |
5291190 | Scarola et al. | Mar 1994 | A |
5295062 | Fukshima | Mar 1994 | A |
5301301 | Kodosky et al. | Apr 1994 | A |
5307263 | Brown | Apr 1994 | A |
5315530 | Gerhardt et al. | May 1994 | A |
5317506 | Coutre et al. | May 1994 | A |
5321601 | Riedel et al. | Jun 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5339821 | Fujimoto | Aug 1994 | A |
5350411 | Ryan et al. | Sep 1994 | A |
5353316 | Scarola et al. | Oct 1994 | A |
5354273 | Hagen | Oct 1994 | A |
5356378 | Doan | Oct 1994 | A |
5357427 | Langen et al. | Oct 1994 | A |
5363482 | Victor et al. | Nov 1994 | A |
5364346 | Schrezenmeir | Nov 1994 | A |
5368562 | Blomquist et al. | Nov 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5383855 | Nicholson et al. | Jan 1995 | A |
5386360 | Wilson et al. | Jan 1995 | A |
5388202 | Squires et al. | Feb 1995 | A |
5389071 | Kawahara et al. | Feb 1995 | A |
5389078 | Zelesky et al. | Feb 1995 | A |
5395321 | Kawahara et al. | Mar 1995 | A |
5400246 | Wilson et al. | Mar 1995 | A |
5412400 | Takahara et al. | May 1995 | A |
5429602 | Hauser | Jul 1995 | A |
5431627 | Pastrone et al. | Jul 1995 | A |
5432709 | Vollweiler et al. | Jul 1995 | A |
5440585 | Partridge, III | Aug 1995 | A |
5456691 | Snell | Oct 1995 | A |
5478211 | Dominiak et al. | Dec 1995 | A |
5479643 | Bhaskar et al. | Dec 1995 | A |
5481250 | Hano | Jan 1996 | A |
5482446 | Williamson et al. | Jan 1996 | A |
5485408 | Blomquist | Jan 1996 | A |
5531697 | Olsen et al. | Jul 1996 | A |
5531698 | Olsen | Jul 1996 | A |
5537436 | Bottoms et al. | Jul 1996 | A |
5558640 | Pfeiler et al. | Sep 1996 | A |
5569187 | Kaiser | Oct 1996 | A |
5573506 | Vasko | Nov 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5594786 | Chaco et al. | Jan 1997 | A |
5598420 | Kaufman | Jan 1997 | A |
5616121 | McKay | Apr 1997 | A |
5626144 | Tacklind et al. | May 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5643212 | Coutre et al. | Jul 1997 | A |
5647854 | Olsen et al. | Jul 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5658252 | Johnson | Aug 1997 | A |
5660176 | Iliff | Aug 1997 | A |
5665065 | Colman et al. | Sep 1997 | A |
5669877 | Blomquist | Sep 1997 | A |
5681285 | Ford et al. | Oct 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5687734 | Dempsey et al. | Nov 1997 | A |
5695473 | Olsen | Dec 1997 | A |
5704366 | Tacklind et al. | Jan 1998 | A |
5706458 | Koppolu | Jan 1998 | A |
5717603 | McClendon et al. | Feb 1998 | A |
5718562 | Lawless et al. | Feb 1998 | A |
5719761 | Gatti et al. | Feb 1998 | A |
5764159 | Neftel | Jun 1998 | A |
5772635 | Dastur et al. | Jun 1998 | A |
5781442 | Engleson et al. | Jul 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5788669 | Peterson | Aug 1998 | A |
5807336 | Russo et al. | Sep 1998 | A |
5810771 | Blomquist | Sep 1998 | A |
5814015 | Gargano et al. | Sep 1998 | A |
5822715 | Worthington et al. | Oct 1998 | A |
5857967 | Frid et al. | Jan 1999 | A |
5861018 | Feierbach | Jan 1999 | A |
5868669 | Iliff | Feb 1999 | A |
5871465 | Vasko | Feb 1999 | A |
5876370 | Blomquist | Mar 1999 | A |
5879163 | Brown et al. | Mar 1999 | A |
5885245 | Lynch et al. | Mar 1999 | A |
5895371 | Levitas et al. | Apr 1999 | A |
5897493 | Brown | Apr 1999 | A |
5899855 | Brown | May 1999 | A |
5913310 | Brown | Jun 1999 | A |
5918603 | Brown | Jul 1999 | A |
5925021 | Castellano et al. | Jul 1999 | A |
5933136 | Brown | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5935106 | Olsen | Aug 1999 | A |
5940801 | Brown | Aug 1999 | A |
5956501 | Brown | Sep 1999 | A |
5960403 | Brown | Sep 1999 | A |
5966691 | Kibre et al. | Oct 1999 | A |
5997476 | Brown | Dec 1999 | A |
6012034 | Hamparian et al. | Jan 2000 | A |
6024539 | Blomquist | Feb 2000 | A |
6032119 | Brown et al. | Feb 2000 | A |
6077055 | Vilks | Jun 2000 | A |
6101478 | Brown | Aug 2000 | A |
RE36871 | Epstein et al. | Sep 2000 | E |
6241704 | Peterson et al. | Jun 2001 | B1 |
6246992 | Brown | Jun 2001 | B1 |
6248067 | Causey, III et al. | Jun 2001 | B1 |
6269340 | Ford et al. | Jul 2001 | B1 |
6406426 | Reuss et al. | Jun 2002 | B1 |
6422057 | Anderson | Jul 2002 | B1 |
6475180 | Peterson et al. | Nov 2002 | B2 |
6551276 | Mann et al. | Apr 2003 | B1 |
6554798 | Mann et al. | Apr 2003 | B1 |
6558320 | Causey, III et al. | May 2003 | B1 |
6641533 | Causey, III et al. | Nov 2003 | B2 |
6671563 | Engelson et al. | Dec 2003 | B1 |
6689091 | Bui et al. | Feb 2004 | B2 |
6744350 | Blomquist | Jun 2004 | B2 |
6749586 | Vasko | Jun 2004 | B2 |
6765877 | Foschiano et al. | Jul 2004 | B1 |
6790198 | White et al. | Sep 2004 | B1 |
6809653 | Mann et al. | Oct 2004 | B1 |
6852104 | Blomquist | Feb 2005 | B2 |
6872200 | Mann et al. | Mar 2005 | B2 |
6898540 | Davies | May 2005 | B2 |
6903743 | Ng | Jun 2005 | B2 |
6904434 | Wallach et al. | Jun 2005 | B1 |
6936029 | Mann et al. | Aug 2005 | B2 |
6956572 | Zaleski | Oct 2005 | B2 |
6979326 | Mann et al. | Dec 2005 | B2 |
6997920 | Mann et al. | Feb 2006 | B2 |
6999854 | Roth | Feb 2006 | B2 |
7025743 | Mann et al. | Apr 2006 | B2 |
7033338 | Vilks et al. | Apr 2006 | B2 |
7036089 | Bauer | Apr 2006 | B2 |
7041082 | Blomquist et al. | May 2006 | B2 |
7042643 | Miles | May 2006 | B2 |
7098803 | Mann et al. | Aug 2006 | B2 |
7103578 | Beck et al. | Sep 2006 | B2 |
7109878 | Mann et al. | Sep 2006 | B2 |
7233781 | Hunter et al. | Jun 2007 | B2 |
7300418 | Zaleski | Nov 2007 | B2 |
7324012 | Mann et al. | Jan 2008 | B2 |
7347836 | Peterson | Mar 2008 | B2 |
D570363 | Ulm et al. | Jun 2008 | S |
D576175 | Onodera | Sep 2008 | S |
D580948 | Tomizawa et al. | Nov 2008 | S |
D586351 | Gelman et al. | Feb 2009 | S |
D586357 | Jasinski | Feb 2009 | S |
D604741 | DeBelser et al. | Nov 2009 | S |
7647237 | Malave et al. | Jan 2010 | B2 |
7654976 | Peterson et al. | Feb 2010 | B2 |
7689939 | Becker | Mar 2010 | B1 |
7708717 | Estes et al. | May 2010 | B2 |
8149131 | Blomquist | Apr 2012 | B2 |
8234128 | Martucci et al. | Jul 2012 | B2 |
8250483 | Blomquist | Aug 2012 | B2 |
8313433 | Cohen et al. | Nov 2012 | B2 |
8412147 | Hunter et al. | Apr 2013 | B2 |
8435206 | Evans et al. | May 2013 | B2 |
8952794 | Blomquist | Feb 2015 | B2 |
9135393 | Blomquist | Sep 2015 | B1 |
20010031944 | Peterson et al. | Oct 2001 | A1 |
20020029776 | Blomquist | Mar 2002 | A1 |
20020107476 | Mann et al. | Aug 2002 | A1 |
20020151804 | O'Mahony et al. | Oct 2002 | A1 |
20020183693 | Peterson et al. | Dec 2002 | A1 |
20020193679 | Malave et al. | Dec 2002 | A1 |
20030011646 | Levine et al. | Jan 2003 | A1 |
20030060765 | Campbell et al. | Mar 2003 | A1 |
20030069650 | Karmiy et al. | Apr 2003 | A1 |
20030114836 | Estes et al. | Jun 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030144880 | Talachian et al. | Jul 2003 | A1 |
20030145053 | Bodin | Jul 2003 | A1 |
20030163088 | Blomquist | Aug 2003 | A1 |
20030163223 | Blomquist | Aug 2003 | A1 |
20030163789 | Blomquist | Aug 2003 | A1 |
20030173408 | Mosher et al. | Sep 2003 | A1 |
20030204415 | Knowlton | Oct 2003 | A1 |
20030204416 | Radpay et al. | Oct 2003 | A1 |
20030212364 | Mann | Nov 2003 | A1 |
20030212379 | Bylund et al. | Nov 2003 | A1 |
20040010425 | Wilkes et al. | Jan 2004 | A1 |
20040065321 | Stenzler | Apr 2004 | A1 |
20040073095 | Causey, III et al. | Apr 2004 | A1 |
20040167465 | Mihai et al. | Aug 2004 | A1 |
20040167804 | Simpson et al. | Aug 2004 | A1 |
20040172301 | Mihai et al. | Sep 2004 | A1 |
20040172302 | Martucci et al. | Sep 2004 | A1 |
20040176984 | White et al. | Sep 2004 | A1 |
20040249673 | Smith | Dec 2004 | A1 |
20050001797 | Miller | Jan 2005 | A1 |
20050010258 | Peterson et al. | Jan 2005 | A1 |
20050030164 | Blomquist | Feb 2005 | A1 |
20050055242 | Bello et al. | Mar 2005 | A1 |
20050065817 | Mihai et al. | Mar 2005 | A1 |
20050137530 | Campbell et al. | Jun 2005 | A1 |
20050143864 | Blomquist | Jun 2005 | A1 |
20050144182 | Boris et al. | Jun 2005 | A1 |
20050171513 | Mann et al. | Aug 2005 | A1 |
20050177096 | Bollish et al. | Aug 2005 | A1 |
20050177395 | Blomquist | Aug 2005 | A1 |
20050246416 | Blomquist | Nov 2005 | A1 |
20060001550 | Mann et al. | Jan 2006 | A1 |
20060026205 | Butterfield | Feb 2006 | A1 |
20060031094 | Cohen et al. | Feb 2006 | A1 |
20060041222 | Dewing et al. | Feb 2006 | A1 |
20060079768 | Small et al. | Apr 2006 | A1 |
20060089539 | Miodownik et al. | Apr 2006 | A1 |
20060132292 | Blomquist | Jun 2006 | A1 |
20060202859 | Mastrototaro et al. | Sep 2006 | A1 |
20060229557 | Fathallah et al. | Oct 2006 | A1 |
20060258985 | Russell | Nov 2006 | A1 |
20070094046 | Cobbs et al. | Apr 2007 | A1 |
20070156033 | Causey, III et al. | Jul 2007 | A1 |
20070213657 | Jennewine et al. | Sep 2007 | A1 |
20070255322 | Gerber et al. | Nov 2007 | A1 |
20070258395 | Jollota | Nov 2007 | A1 |
20080030369 | Mann et al. | Feb 2008 | A1 |
20080033357 | Mann et al. | Feb 2008 | A1 |
20080033360 | Evans | Feb 2008 | A1 |
20080033361 | Evans et al. | Feb 2008 | A1 |
20080033749 | Blomquist | Feb 2008 | A1 |
20080034323 | Blomquist | Feb 2008 | A1 |
20080065007 | Peterson et al. | Mar 2008 | A1 |
20080065016 | Peterson et al. | Mar 2008 | A1 |
20080126969 | Blomquist | May 2008 | A1 |
20080132844 | Peterson et al. | Jun 2008 | A1 |
20080300534 | Blomquist | Dec 2008 | A1 |
20090177180 | Rubalcaba et al. | Jul 2009 | A1 |
20090275886 | Blomquist et al. | Nov 2009 | A1 |
20100020064 | Roosendaal et al. | Jan 2010 | A1 |
20120172802 | Blomquist | Jul 2012 | A1 |
20130012878 | Blomquist | Jan 2013 | A1 |
20130012879 | Debelser et al. | Jan 2013 | A1 |
20130012880 | Blomquist | Jan 2013 | A1 |
20130015980 | Evans et al. | Jan 2013 | A1 |
20130018315 | Blomquist | Jan 2013 | A1 |
20130131630 | Blomquist | May 2013 | A1 |
20140027657 | Smith et al. | Jan 2014 | A1 |
20140094744 | Blomquist | Apr 2014 | A1 |
20140094764 | Blomquist | Apr 2014 | A1 |
20140095485 | Blomquist | Apr 2014 | A1 |
20140095499 | Blomquist | Apr 2014 | A1 |
20140351712 | Blomquist | Nov 2014 | A1 |
20150072613 | Swanson | Mar 2015 | A1 |
Number | Date | Country |
---|---|---|
2060151 | Aug 1992 | CA |
665955 | Jun 1988 | CH |
0069350 | Jan 1983 | EP |
0078645 | May 1983 | EP |
0183351 | Jun 1986 | EP |
0188288 | Jul 1986 | EP |
0221005 | May 1987 | EP |
0233115 | Aug 1987 | EP |
319272 | Jun 1989 | EP |
0328162 | Aug 1989 | EP |
0384155 | Aug 1990 | EP |
408483 | Jan 1991 | EP |
0497041 | Aug 1992 | EP |
503670 | Sep 1992 | EP |
0371507 | Mar 1993 | EP |
551088 | Jul 1993 | EP |
0806738 | Dec 1997 | EP |
0952541 | Oct 1999 | EP |
1587017 | Oct 2005 | EP |
1647291 | Apr 2006 | EP |
2603488 | Mar 1988 | FR |
2675288 | Oct 1992 | FR |
2039083 | Jul 1980 | GB |
2262452 | Jun 1993 | GB |
2312055 | Oct 1997 | GB |
409192218 | Jul 1997 | JP |
2002291706 | Oct 2002 | JP |
WO8703814 | Jul 1987 | WO |
WO8707161 | Dec 1987 | WO |
WO9116609 | Oct 1991 | WO |
WO9208647 | May 1992 | WO |
WO9215439 | Sep 1992 | WO |
WO9405355 | Mar 1994 | WO |
WO9408647 | Apr 1994 | WO |
WO 8403218 | Aug 1994 | WO |
WO9502426 | Jan 1995 | WO |
WO9525893 | Sep 1995 | WO |
WO9528190 | Oct 1995 | WO |
WO9603168 | Feb 1996 | WO |
WO9613790 | May 1996 | WO |
WO9620745 | Jul 1996 | WO |
WO9636389 | Nov 1996 | WO |
WO9725083 | Jul 1997 | WO |
WO9715227 | Apr 1998 | WO |
WO9820439 | May 1998 | WO |
WO9824358 | Jun 1998 | WO |
WO9842407 | Oct 1998 | WO |
WO9859487 | Dec 1998 | WO |
WO9908183 | Feb 1999 | WO |
WO9910801 | Mar 1999 | WO |
WO9918532 | Apr 1999 | WO |
WO9922236 | May 1999 | WO |
WO0045696 | Aug 2000 | WO |
WO0048112 | Aug 2000 | WO |
WO 0152727 | Jul 2001 | WO |
WO0211049 | Feb 2002 | WO |
WO03053503 | Jul 2003 | WO |
WO03094075 | Nov 2003 | WO |
WO2005056083 | Jun 2005 | WO |
WO2005083619 | Sep 2005 | WO |
WO2006023636 | Mar 2006 | WO |
WO2006073400 | Jul 2006 | WO |
WO2007101260 | Sep 2007 | WO |
WO2008019013 | Feb 2008 | WO |
WO2008019014 | Feb 2008 | WO |
WO2008019015 | Feb 2008 | WO |
WO2008016621 | Feb 2008 | WO |
WO2008048587 | Apr 2008 | WO |
WO2008019016 | Nov 2008 | WO |
WO2009135108 | Nov 2009 | WO |
Entry |
---|
DVD—University of Maryland at College Park MD. Human-Computer Interaction Laboratory, Apr. 1991. (2 copies). |
DVD—University of Maryland at College Park MD. Human-Computer Interaction Laboratory, Apr. 1992. (2 copies). |
Invitation to Pay Additional Fees with Partial International Search for International Application No. PCT/US2007/017133 mailed Feb. 27, 2008. |
International Search Report for International Application No. PCT/US94/07582 dated Oct. 28, 1994. |
Notification of Reasons for Refusal for Japanese Patent Application No. 2006542752 dated Jun. 23, 2010. |
Steinfeld, Internet-Appliance Technology Automates Test Equipment. pp. 157-169. Oct. 12, 2000. |
Merritt, “Wireless Hospital Health Care Products on the Upswing”, Jan. 7, 2004. |
Steinfeld, Is Embedded Going Net-Crazy?? A Response. Internet Article Mar. 29, 2001. |
Written Opinion for International Application No. PCT/US2007/017122 dated Feb. 19, 2008. |
International Search Report for International Application No. PCT/US2005/005829 dated Nov. 10, 2005. |
Written Opinion for International Application No. PCT/US2005/005829 dated Nov. 10, 2005. |
International Search Report for International Application No. PCT/US2004/040397 dated Feb. 7, 2006. |
Written Opinion for International Application No. PCT/US2004/040397 dated Feb. 7, 2006. |
International Search Report for International Application No. PCT/US2007/017138 dated Nov. 20, 2007. |
Written Opinion for International Application No. PCT/US2007/017138 dated Nov. 20, 2007. |
Written Opinion for International Application No. PCT/US2007/017123 dated Jan. 25, 2008. |
International Search Report for International Application No. PCT/US2007/017120 dated Jan. 25, 2008. |
Written Opinion for International Application No. PCT/US2007/017120 dated Jan. 25, 2008. |
European Office Action for European Application No. 05713999 dated Oct. 30, 2009. |
International Search Report for International Application No. PCT/US2007/017133 dated May 8, 2008. |
Written Opinion for International Application No. PCT/US2007/017133 dated May 8, 2008. |
International Search Report for International Application No. PCT/US2007/022051 dated Mar. 7, 2008. |
Written Opinion for International Application No. PCT/US2007/022051 dated Mar. 7, 2008. |
Declaration of non-establishment of ISR for International Application No. PCT/US2009/042494 dated Jan. 5, 2010. |
Written Opinion for International Application No. PCT/US2009/042494 dated Jan. 5, 2010. |
European Office Action for European Application No. 07797060 dated Jul. 3, 2009. |
European Office Action for European Application No. 07797060 dated Feb. 9, 2010. |
European Office Action for European Application No. 07797060 dated Dec. 8, 2010. |
Australian Office Action for Application No. 2004296794 dated Dec. 3, 2009. |
Notice of Acceptance of Australian Application No. 2007282068 dated Feb. 11, 2014. |
Canadian Office Action for Canadian Application No. 2659485 dated Mar. 27, 2014. |
Canadian Office Action for Canadian Application No. 2659629 dated May 8, 2014. |
Canadian Office Action for Canadian Application No. 2659494 dated May 12, 2014. |
International Search Report and Written Opinion for International Application No. PCT/US2007/017122 dated Feb. 19, 2008. |
International Search Report and Written Opinion for International Application No. PCT/US2007/017123 dated Jan. 25, 2008. |
Decision to refuse European Application for European Application No. 07836389.2-2201 dated Dec. 18, 2012. |
Decision to refuse European Application for European Application No. 07836379.3-2201 dated Dec. 18, 2012. |
Australian Examiner's first report on Australian Application No. 2007282068 dated May 10, 2012. |
Canadian Office Action for Canadian Application No. 2,659,485 dated Aug. 22, 2013. |
Devices for Insulin Administration , Jean-Louis Selam, MD and M. Arthur Charles, MD, PhD., Diabetes Care, vol. 13, No. 9, Sep. 1990, pp. 955-979. |
A Semi-closed loop computer-assisted insulin infusion system, Donald J. Chisholm, Edward W. Kraegen, David J. Bell and David R, Chipps, The Medical Journal of Australia, Dec. 8/22, 1984, pp. 13-17. |
Hypertensive Crisis Managed by Computer-Controlled Infusion of Sodium Nitroprusside; A Model for the Closed-Loop Administration of Short-Acting Vasoactive Agents. Jeremy J, Hammond, Walter M. Kirkdendall, Richard V. Calfee, Computers and Biomedical Research, vol. 12, pp. 97-108, 1979. |
Computerized Continuous Infusion of Intravenous Anesthetic Drugs During Pediatric Cardiac Surgery; Kern FH, Ungerleider RM, Jacobs JR, Boyd JL 3rd, Reves JG, Goodman D. Greeley WJ; Department of Anesthesiology, Duke Heart Center, Duke University Medical Center, Durham, North Carolina, Anesth Analg. Apr. 1991; 72(4): 487-92. |
Use of a Microprocessor in the Control of Malignant Hypertension with Sodium Nitroprusside, Jackson RV, Love JB, Parkin WG, Wahlquist ML, Williams NS, Aust N Z J Med. Aug. 1977; 7(4):414-7. |
Effective Control of Blood Pressure by Computerized Infusion of Sodium Nitroprusside, R.V. Calfee, J.J. Hammond, W.M. Kirkendall, Clinical Research, vol. 25, 1977. |
Automated Patient Care Following Cardiac Surgery, Nicholas T. Kouchoukos; Louis B. Sheppard; John W. Kirklin, Cardiovascular Clinics, Bol. 3, pp. 110-120, 1971. |
A Simulation Study on a Self-Tuning Portable Controller of Blood Glucose. Brunetti P, Cobelli C, Cruciani P, Fabietti PG, Filippucci F, Santeusanio F, Sarti E. Medical Pathology Institute, Bioengineering Laboratory, University of Perugia, Italy. Int. J. ArtifOrgans. Jan. 1993; 16(1):51-7. |
A Semi-Closed Loop Computer-Assisted Insulin Infusion System. Hospital use for Control of Diabetes in Patients, Chisholm DJ, Kraegan EW, Bell DJ, Chipps DR, Med J. Aust. Dec. 8-22, 1984;141(12-13):784-9. |
Patient-controlled Portable Insulin Infusion Pump in Diabetes, Jergen Bojsen, Thorsten Deckert, Klaus Kelendorf, and Birthe Lerup, Diabetes Vol, Nov. 28, 1979. Cover page and pp. 974-979. |
Block Medical: Growing awith Home Infusion Therapy, In Vivio, The Business and Medicine Report, Apr. 1991, 3 pages. |
Abbot Literature, 37 pages as submitted Jun. 29, 1998 in U.S. Appl. No. 08/868,913. |
Baxter Literature for MultiPlex™ Series 100 Fluid Management System, 4 pages, as submitted Jun. 29, 1988 in U.S. Appl. No. 08/868,913. |
Baxter Literature for Flo-Guard® 6201 Volumetric Infusion Pump, Copyright 1992, 2 pages. |
Greg Sancoff. San Diego Executive, “A Better Mousetrap,” Sep. 1989, 4 pages. |
Blade-Citizen, “Entrepeneur takes Aim at Home Health Care Market,” Dec. 31, 1989, 2 pages. |
“Product Overview, Verifuse Ambulatory Infusion Pump.” Block Medical Inc, dated Sep. 1990, 4 pages. |
Peter Lord et al., “MinMed Technologies Programmable Implantable Infusion System,” pp. 66-91, from Annals of the New York Academy of Sciences, Neurilogical Applications of Implanted Drug Pumps, Copyright 1988. |
Dertouzos, M., “Communications, Computers & Net-works,” Scientific American Sep. 1991, pp. 62-69. |
Dehne, T., “PC-Based Data Acquisition and Instrumentation,” Analytical Chemistry, vol. 62, No. 9, May 1, 1990. pp. 565A, 566A, 568A, 570A, 571A, 572A. |
“ally™ Ambulatory Drug Infusion System”, Q-Life Systems Inc., 3 pages, as Jun. 29, 1988 in U.S. Appl. No. 08/868,913. |
Fundamentals of Interactive Computer Graphics, Foley et al., Mar. 1993, pp. 10, 11, 29-35. |
IMED STATUS Infusion Management System literature, 6 pages, as submitted Jun. 29, 1988 in U.S. Appl. No. 08/868,913. |
Linkens et al., Computer Control Systems and Pharmacological Drug Administration: A Survey, Journal of Medical Engineering & Technology, vol. 14, No. 2, Mar./Apr. 1990, pp. 41-54. |
McCarthy, LH, Software Simulates Instrumentation Systems, Design News, May 21, 1990, pp. 72-73. |
National Instruments Document entitled “Scientific Data Analysis,” 16 pages, as submitted Jun. 29, 1988 in U.S. Appl. No. 08/868,913. |
National Instruments Instrumentation Newsletter, Aug. 1990, 20 pages. vol. 2, No. 3. |
National Instruments Instrumentation Newsletter, Feb. 1991, 20 pages. vol. 3, No. 1. |
National Instruments Instrumentation Newsletter, May 1990, 18 pages. vol. 2, No. 2. |
National Instruments Instrumentation Newsletter, Nov. 1990, 16 pages. vol. 2, No. 4. |
National Instruments Lab Windows 2.0 materials, 6 pages, as Jun. 29, 1988 in U.S. Appl. No. 08/868,913. |
National Instruments Lab Windows 1.2 materials dated Oct. 1989, 5 pages. |
Bedder, M. et al., “Cost Analysis of Two Implantable Narcotic Delivery Systems,” Journal of Pain and Symptom Management. vol. 6, No. 6, Aug. 1991. pp. 368-373. |
Principles and Guidelines in Software User Interface Design, Deborah J. Mayhew, Chapter 9 Dialog Styles: Direct Manipulation, copyright 1992, 17 pages. |
Advertisement from HERCO, Are Control Rooms Obsolete? Dated Mar. 1971, 1 page and Mar. 1972, 1 page. |
Electronics Feb. 1990 article entitled “Who Will Dominate the Desktop in the '90's?”, 3 pages. |
The Orange County Register No. 21, 1991 article entitled “Portable TV frees patients,” 1 page. |
Article by McMorris et al., “Are Process Control Rooms Obsolete?”, Control Engineering dated Jul. 1971, pp. 42-47. |
LabVIEW® User Manual, Jan. 1990 Edition, cover page and pp. 2-1 through 2-36. |
National Instruments' 1991 catalog entitled “IEEE-488 and VXIbus Control, Data Acquisition, and Analysis,” cover page and pp. 1-1 through 1-13, 1-38, 4-68 and 4-69. |
Abbot Laboratories Blue Line System Life Care® Model 4 Series System brochure, copyright 1990, 16 pages. |
Operator's Manual for a CADD-Micro™ Ambulatory Infusion Pump Model 5400, front cover and pp. ii-vi, pp. 1-55 and two back cover pages, copyright 1990. |
Lahti W. et al., “Byte”, pp. 311-318, Nov. 1990. “Store Data in a Flash”. |
Operator's Manual for a CADD-Micro® Ambulatory Infusion Pump Model 5900, front cover and pp. ii-vi and 1-84, copyright 1993. |
Sheppard, L.C., Computer based Clinical Systems: Automation and Intergration, 39th Annual Conference on Engineering in Medicine and Biology, Baltimore, Maryland, Sep. 13-16, 1986, pp. 73-75. |
Intravenous propofol anaesthesia using a computerized infusion system, M. White and G.N.C. Kenny, Anaesthesia, 1990, vol. 45, pp. 204-209. |
Health Devices, ECRI A Nonprofit Agency, vol. 17 No. 12, Dec. 1988. |
Health Devices, ECRI A Nonprofit Agency, vol. 19 Nos. 3-4, Mar.-Apr. 1989. |
Operator's Manual, Gemini® PC-1 Volumetric Infusion Pump/Controller imed® Aug. 16, 1990. |
Model 929 Computer Controlled Volumetric Infusion Pump Operating Instructions imed® , as submitted Feb. 28, 2008 in U.S. Appl. No. 11/981,788. |
Pain Control Devices Gaining Acceptance, Will Expand-Analgesic Delivery Devices-Industry Overview, http://www.findarticles.com/articles/mi—m3498/is—n5—v55/ai—12257770, Sep. 29, 2004. |
A Standard Microcomputer Linked to a Volume-Controlled Infusion Pump for Patient-Controlled Analgesia Research, Journal of Medical Engineering and Technology, G.W.A. Gillies, G.N.C. Kenny and C.S. McArdle, vol. 10, No. 2, Mar./Apr. 1986. pp. 55-57. |
The P1073 Medical Information Bus, David F. Franklin and David V. Ostler (Oct. 1989). |
IMED 980 Volumetric Infusion Pump Operator's Manual. 1992. |
Improving Acute Care Use of Medical Device Data, Robert J. Kennelly, Chair, IEEE 1073 “Standard for Medical Device Communications” Committee, Eden Shores Consulting. 1992. |
Health Devices, ECRI A Nonprofit Agency, Sep. 1991, vol. 20, No. 9. |
Medtronic MiniMed Paradigm Link Owner's Guide, BD Logic, 2003. |
M68HCII E Series, HCMOS Microcontroller Unit, Motorola, Inc. 1993, 1996. |
Health Devices, ECRI A Nonprofit Agency, Dec. 1989, vol. 18 No. 12. |
Health Devices, ECRI A Nonprofit Agency, Dec. 1991, vol. 20 No. 12. |
510 (k) Registration Documents for Registration of K87022 and K871728 (1987). |
510 (k) Registration Documents for Registration of K863997 (1986). |
Complaint for Patent Infringement (Exhibits 1-3); C.A. No. 03-776, Medtronic Minimed, Inc. v. Deltec Inc., and Smiths Medical Ltd. Aug. 5, 2003. |
First Amended Complaint for Patent Infringement (Exhibits 1-3); C.A. No. 03-776, Medtronic Minimed, Inc. v. Deltec Inc. Smiths Group North America Inc. and Smiths Medical Ltd. |
Answer and Counterclaims of Smiths Medical Md. Inc. (Exhibits 1-5); C.A. 03-776, Medtronic Minimed, Inc, v. Deltec Inc., Smiths Group North America, Inc. and Smiths Group Pic. Nov. 17, 2003. |
Joint Claim Construction Statement (Exhibits 1-2); C.A. No. 03-776, Medtronic Minimed, Inc. v. Smiths Medical Md, Inc. Certificate of service Feb. 4, 2005. |
Expert Response of Anthony Storace on behalf of Defendant Conterclaimant Smiths Medical Md., Inc. to the Expert Report Submitted by jack Goldberg on behalf of Plaintiff Medtronic Minimed (Exhibits B-J); C.A. No. 03-776, Medtronic Minimed Inc. v. Smiths Medical Md, Inc. Jan. 14, 2005. |
Application and File History for U.S. Appl. No. 08/978,779, filed Nov. 26, 1997, inventor Blomquist. |
Application and File History for U.S. Appl. No. 09/324,305, filed Jun. 2, 1999, inventor Peterson. |
Application and File History for U.S. Appl. No. 09/421,751, filed Oct. 20, 1999, inventor Blomquist. |
Application and File History for U.S. Appl. No. 09/795,266, filed Feb. 27, 2001, inventor Peterson. |
Application and File History for U.S. Appl. No. 10/068,291, filed Feb. 5, 2002, inventor Peterson. |
Medtronic Minimed's Reply Brief in Support of it's Motion for Summary Judgment of Non-Infringement of Claims 6 and 11 of Smiths '704 Patent (Exhibits A-B), Medtronic Minimed Inc, v. Smith Medical Md, Inc. Mar. 4, 2005. |
Medtronic Minimed's Reply Brief in Support of its Motion for Summary Judgment of Invalidilty of Claims 6 and 11 of Smiths '704 Patent (Exhibits A-B); C.A. No. 03-776, Medtronic Minimed Inc. v. Smiths Medical MD, Inc. Mar. 4, 2005. |
Defendant Smiths Medical Md. Inc. S. Answering Brief Responding to Medtronic Minimed Inc.'S Claim Construction Brief for U.S. Pat. No. 6,241,704, C.A. No. 03-776, Medtronic Minimed Inc. V. Smiths Medical Md. Inc. Feb. 25, 2005. |
Declaration of Anthony C. Roth in Support of Defendant-Counterclaim Plaintiff Smiths Medical Md, Inc. 'S Response Brief to Medtronic Minimed, Inc.'S Claim Construction Brief of U.S. Pat. No. 6,241,704 (Exhibits A-H); C.A. No. 03-776, Medtronic Minimed Inc. v. Smith Medical Md, Inc. Feb. 25, 2005. |
Defendant Smiths Medical Md, Inc. 'S Brief in Opposition to Medtronic Minimed, Inc 'S Motion for Summary Judgment of Invalidity of Claims 6 and 11 of Smiths Medical Inc. 'S U.S. Pat. No. 6,241,704; C.A. No. 03-776, Medtronic Minimed, Inc. v. Smiths Medical Md. Inc. Feb. 28, 2005. |
Declaration of Anthony C. Roth in Support of Defendant-Counterclaim Plaintiff Smiths Medical Md, Inc. 'S Brief in Opposition of Medtronic Minimed Inc. 'S Motion for Summary Judgment of invalidity of claims 6 and 11 of Smiths Medical Inc. 'S U.S. Pat. No. 6,241,704 (Exhibits 1-7); C,A, No. 03-7769, Medtronic Minimed Inc. v. Smiths Medical Md. Inc. Feb. 28, 2005. |
Expert Report of Jack Goldberg on behalf of Plaintiff Medtronic Minimed Pursuant to Fed R. Civ. P. 26(A)(2) (Exhibits A-F); C.A. No. 03-776, Medtronic Minimed Inc. v. Smiths Medical Md. Inc. Executed Dec. 15, 2004. |
Application and File History for U.S. Appl. No. 08/782,486, filed Jan. 10, 1997, inventor Peterson. |
Application and File History for U.S. Appl. No. 08/800,477, filed Feb. 14, 1997 inventor Blomquist. |
Application and File History for U.S. Appl. No. 08/934,875, filed Sep. 22, 1997, inventor Blomquist. |
Application and File History for U.S. Appl. No. 08/868,913, filed Jun. 4, 1997, inventor Blomquist. |
Opening Brief in Support of Defendant Smiths Medical, Inc.'s Propsed Claim Constructions for U.S. Pat. Nos. 6,241,704; 6,554,065 and 6,554,798 (Exhibits 1-20); C.A. No. 03-776, Medtronic Minimed, Inc. v. Smiths Medical Md, Inc. Feb. 4, 2005. |
Memorandum Opinion: C.A. No. 03-776, Medtronic Minimed, Inc. v. Smiths Medical Md. Inc. Jun. 1, 2005. |
Order: C.A. No. 03-776; Medtronic Minimed Inc. v. Smiths Medical Md. Inc. Jun. 1, 2005. |
Memorandum Opinion (Summary Judgment of Infringement of U.S. Pat. Nos. 5,665,065 and 6,554,798), C.A. No. 03-776, Medtronic Minimed Inc. v. Smiths Medical Md. Inc. Jun. 16, 2005. |
Notification of Reasons for Refusal for Japanese Patent Application No. 2006-554321 dispatch date Apr. 19, 2010. |
Decision of Refusal for Japanese Application No. 2006-554321 dispatch date Apr. 18, 2011. |
Examiner's first report on patent application No. 2005216321 by Smiths Medical ASD, Inc. dated Nov. 26, 2009. Australian Government IP. |
Examiner's report No. 3 on patent application No. 2005216321 by Smiths Medical ASD Inc. dated Apr. 20, 2011, Australian Government IP. |
Notification of Reasons for Refusal for Japanese Application No. 2006-542752 dispatch date Jun. 28, 2010. |
Examiner's first report on patent application No. 2004296794 by Smiths Medical ASD, Inc. dated Dec. 3, 2009. Australian Government IP. |
Examiner's report No. 2 on patent application No. 2005216321 by Smiths Medical ASD, Inc. dated Jan. 7, 2011. Australian Government IP. |
Examiner's first report No. 4 on Australian patent application No. 2005216321 dated Aug. 25, 2011. |
Application and File History for U.S. Appl. No. 08/561,809, filed Nov. 22, 1995, inventor Peterson. |
Application and File History for U.S. Appl. No. 08/586,952, filed Jan. 16, 1996, inventor Blomquist See Application and File History for U.S. Appl. No. 08/782,486, filed Jan. 10, 1997, inventor Peterson. |
Decision of Refusal for Japanese Application No. 2006-542752 dispatch date Jul. 4, 2011. |
Application and File History for U.S. Appl. No. 11/981,229, filed Oct. 31, 2007, inventor Peterson. |
Examiner's first report on Australian patent application No. 2007281512 dated Jul. 4, 2011. |
Examiner's first report on Australian patent application No. 2007282071 dated Jul. 11, 2011. |
Instruction Manual entitled “Quick Start for Speakerphone XT SVD”, copyright 1996. |
Bio Tek Instruments, Inc. Products Catalog 32 pages. Apr. 1992. |
Intel® document entitled “28F001BX-T/28F001BX-B 1M(128K×8) CMOS Flash Memory” dated Mar. 1991. 28 pages. |
Intel® document entitled “28F008SABMBIT (IMBIT×8) Flashtile™ Memory” dated Mar. 1992. 28 pages. |
A Programmable Infusion Pump Controller, 30th Annual Conference on Engineering in Medicine and Biology, Nov. 5-9, 1977 in Los Angeles, CA. 11 pages. |
IV700 Service Manual Valleylab, Inc. Boulder, Colorado. Sep. 1988. |
Designing the User Interface, Ben Schneiderman. Chapter 5 Direct Manipulation. Oct. 1993. 56 pages. |
Provider® One Instruction Manual, Panoretec Inc. as submitted on May 18, 1998 in U.S. Appl. No. 08/782,486. |
Wilson, R. “Integrated Circuits” of Computer Design pp. 26-27 Jun. 1, 1989. |
Zales, S et al., “Microprocessors and Microsystems” vol. 14, No. 8. pp. 543-549. Oct. 1990. |
Notice of Acceptance for Australian Application No. 2007282070 dated Oct. 3, 2013. |
European Office Communication for European Application No. 07810949.3-1662 dated Feb. 25, 2013. |
Australian Examination Report No. 3 for Australian Application No. 2007282068 dated Jun. 4, 2013. |
Australian Examination Report No. 3 for Australian Application No. 2007282068 dated Jun. 17, 2013. |
European Office Communication for European Application No. 07810948.5-1662 dated Feb. 25, 2013. |
Australian Patent Examination Report No. 2 for Australian Application No. 2007282068 dated Dec. 17, 2012. |
Australian Patent Examination Report No. 2 for Australian Application No. 2007282070 dated Nov. 2, 2012. |
European Office Communication for European Application No. 07836379.3-2201/2050037 dated Jul. 18, 2012. |
Australian Examiner's first report on Australian Application No. 2007282069 dated Jul. 11, 2011. |
European Office Communication for European Application No. 07797060.6-2201/2050032 dated Dec. 8, 2010. |
Application and File History for U.S. Appl. No. 11/499,248, filed Aug. 3, 2006, inventor Blomquist. |
Application and File History for U.S. Appl. No. 11/499,240, filed Aug. 8, 2006, inventor Blomquist. |
Application and File History for U.S. Appl. No. 13/620,031, filed Sep. 14, 2012, inventor Blomquist. |
Application and File History for U.S. Appl. No. 11/702,925, filed Feb. 5, 2007, inventors Evans et al. |
Application and File History for U.S. Appl. No. 13/619,964, filed Sep. 14, 2012, inventors Evans et al. |
Application and File History for U.S. Appl. No. 08/276,025, filed Jul. 15, 1994, inventor Blomquist. |
Application and File History for U.S. Appl. No. 08/540,960, filed Oct. 11, 1995, inventor Blomquist See Application and File History for U.S. Appl. No. 08/782,486, filed Jan. 10, 1997, inventor Peterson. |
Application and File History for U.S. Appl. No. 08/555,304, filed Nov. 8, 1995, inventor Blomquist. |
Application and File History for U.S. Appl. No. 11/702,922, filed Feb. 5, 2007 inventor Evans. |
Application and File History for U.S. Appl. No. 11/499,893, filed Aug. 3, 2006, inventor Blomquist. |
Application and File History for U.S. Appl. No. 11/499,255, filed Aug. 3, 2006, inventor Blomquist. |
Application and File History for U.S. Appl. No. 13/419,138 filed Mar. 13, 2012, inventor Blomquist. |
Canadian Office Action dated May 4, 2015 for Canadian Application No. 2,659,629. |
Application and File History for Design U.S. Appl. No. 29/306,071, filed Apr. 1, 2008, inventor DeBleser et al. |
Application and File History for U.S. Appl. No. 10/087,449, filed Feb. 28, 2002, inventor Blomquist. |
Application and File History for U.S. Appl. No. 11/066,425, filed Feb. 22, 2005, inventor Blomquist. |
Application and File History for U.S. Appl. No. 11/003,147, filed Dec. 3, 2004, inventor Blomquist. |
Application and File History for U.S. Appl. No. 10/087,205, filed Feb. 28, 2002, inventor Blomquist. |
Application and File History for U.S. Appl. No. 11/981,788, filed Oct. 31, 2007, inventor Peterson et al. |
Application and File History for U.S. Appl. No. 11/981,248, filed Oct. 31, 2007, inventor Peterson et al. |
Application and File History for U.S. Appl. No. 12/114,033, filed May 2, 2008, inventor Blomquist. |
Application and File History for U.S. Appl. No. 07/942,288, filed Sep. 9, 1992, inventor Blomquist. |
Application and File History for U.S. Appl. No. 08/090,738, filed Jul. 13, 1993, inventor Blomquist See Application and File History for U.S. Appl. No. 08/555,304, filed Nov. 8, 1995, inventor Blomquist. |
Application and File History for U.S. Appl. No. 08/206,737, filed Mar. 7, 1994, inventor Blomquist. |
Canadian Examiner's Report for Canadian Application No. 2,659,629 dated Aug. 8, 2016. |
Number | Date | Country | |
---|---|---|---|
20150081894 A1 | Mar 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13419138 | Mar 2012 | US |
Child | 14500006 | US | |
Parent | 11499255 | Aug 2006 | US |
Child | 13419138 | US |